Prof. E.S.G. Stroes MD PhD publications

2020

• Mach François, Baigent Colin, Catapano Alberico L., Koskinas Konstantinos C., Casula Manuela, Badimon Lina, Chapman M. John, De Backer Guy G., Delgado Victoria, Ference Brian A., Graham Ian M., Halliday Alison, Landmesser Ulf, Mihaylova Borislava, Pedersen Terje R., Riccardi Gabriele, Richter Dimitrios J., Sabatine Marc S., Taskinen Marja Riitta, Tokgozoglu Lale, Wiklund Olov, Mueller Christian, Drexel Heinz, Aboyans Victor, Corsini Alberto, Doehner Wolfram, Farnier Michel, Gigante Bruna, Kayikcioglu Meral, Krstacic Goran, Lambrinou Ekaterini, Lewis Basil S., Masip Josep, Moulin Philippe, Petersen Steffen, Petronio Anna Sonia, Piepoli Massimo Francesco, Pinto Xavier, Raber Lorenz, Ray Kausik K., Reiner Zeljko, Riesen Walter F., Roffi Marco, Schmid Jean Paul, Shlyakhto Evgeny, Simpson Iain A., Stroes Erik, Sudano Isabella, Tselepis Alexandros D., Viigimaa Margus 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk European heart journal 2020;41 (1):111-188 [PubMed]
• Ibrahim Shirin, Reeskamp Laurens F., Stroes Erik S. G., Watts Gerald F. Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods Current opinion in lipidology 2020;31 (6):347-355 [PubMed]
• Langsted Anne, Bojesen Stig E., Stroes Erik S. G., Nordestgaard B. rge G. AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers Atherosclerosis 2020;312:8-15 [PubMed]
• Hoogeveen Renate M., Stroes Erik S. G., Cornel Jan H. Anti-inflammatoire therapie bij hart- en vaatziekten Nederlands tijdschrift voor geneeskunde 2020;164 (44) [PubMed]
• Cohn Danny M., Viney Nicholas J., Fijen Lauré M., Schneider Eugene, Alexander Veronica J., Xia Shuting, Kaeser Gwendolyn E., Nanavati Charvi, Baker Brenda F., Geary Richard S., Levi Marcel, Meijers Joost C. M., Stroes Erik S. G. Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema New England journal of medicine 2020;383 (13):1242-1247 [PubMed]
• Arsenault Benoit J., Pelletier William, Kaiser Yannick, Perrot Nicolas, Couture Christian, Khaw Kay-Tee, Wareham Nicholas J., Bossé Yohan, Pibarot Philippe, Stroes Erik S. G., Mathieu Patrick, Thériault S. bastien, Boekholdt S. Matthijs Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease-Free Survival, and Mortality Risk: A Mendelian Randomization Analysis JAMA network open 2020;3 (2):e200129 [PubMed]
• Schnitzler Johan G., Hoogeveen Renate M., Ali Lubna, Prange Koen H. M., Waissi Farahnaz, van Weeghel Michel, Bachmann Julian C., Versloot Miranda, Borrelli Matthew J., Yeang Calvin, de Kleijn Dominique P. V., Houtkooper Riekelt H., Koschinsky Marlys L., de Winther Menno P. J., Groen Albert K., Witztum Joseph L., Tsimikas Sotirios, Stroes Erik S. G., Kroon Jeffrey Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation Circulation research 2020;126 (10):1346-1359 [PubMed]
• Ballantyne Christie M., Laufs Ulrich, Ray Kausik K., Leiter Lawrence A., Bays Harold E., Goldberg Anne C., Stroes Erik S. G., MacDougall Diane, Zhao Xin, Catapano Alberico L. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy European journal of preventive cardiology 2020;27 (6):593-603 [PubMed]
• Wasiak Sylwia, Dzobo Kim E., Rakai Brooke D., Kaiser Yannick, Versloot Miranda, Bahjat Mahnoush, Stotz Stephanie C., Fu Li, Sweeney Michael, Johansson Jan O., Wong Norman C. W., Stroes Erik S. G., Kroon Jeffrey, Kulikowski Ewelina BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes Clinical epigenetics 2020;12 (1) [PubMed]
• Willeit Peter, Tschiderer Lena, Allara Elias, Reuber Kathrin, Seekircher Lisa, Gao Lu, Liao Ximing, Lonn Eva, Gerstein Hertzel C., Yusuf Salim, Brouwers Frank P., Asselbergs Folkert W., van Gilst Wiek, Anderssen Sigmund A., Grobbee Diederick E., Kastelein John J. P., Visseren Frank L. J., Ntaios George, Hatzitolios Apostolos I., Savopoulos Christos, Nieuwkerk Pythia T., Stroes Erik, Walters Matthew, Higgins Peter, Dawson Jesse, Gresele Paolo, Guglielmini Giuseppe, Migliacci Rino, Ezhov Marat, Safarova Maya, Balakhonova Tatyana, Sato Eiichi, Amaha Mayuko, Nakamura Tsukasa, Kapellas Kostas, Jamieson Lisa M., Skilton Michael, Blumenthal James A., Hinderliter Alan, Sherwood Andrew, Smith Patrick J., van Agtmael Michiel A., Reiss Peter, van Vonderen Marit G. A., Kiechl Stefan, Klingenschmid Gerhard, Sitzer Matthias, Stehouwer Coen D. A., de Groot Eric, Grooteman Muriel P. C. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients Circulation 2020;142 (7):621-642 [PubMed]
• Opstal Tjerk S. J., Hoogeveen Renate M., Fiolet Aernoud T. L., Silvis Max J. M., The Salem H. K., Bax Willem A., de Kleijn Dominique P. V., Mosterd Arend, Stroes Erik S. G., Cornel Jan H. Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy Circulation 2020;142 (20):1996-1998 [PubMed]
• Ali Lubna, Cupido Arjen J., Rijkers Maaike, Hovingh G. Kees, Holleboom Adriaan G., Dallinga-Thie Geesje M., Stroes Erik S. G., van den Boogert Marjolein A. W. Common gene variants in ASGR1 gene locus associate with reduced cardiovascular risk in absence of pleiotropic effects Atherosclerosis 2020;306:15-21 [PubMed]
• Bakermans Adrianus J., Wessel Chang Ho, Zheng Kang H., Groot Paul F. C., Stroes Erik S. G., Nederveen Aart J. Dynamic magnetic resonance measurements of calf muscle oxygenation and energy metabolism in peripheral artery disease Journal of magnetic resonance imaging 2020;51 (1):98-107 [PubMed]
• Pepplinkhuizen Shari, Ibrahim Shirin, Vink Rutger, Groot Bas, Stroes Erik S. G., Bax Willem A., Cornel Jan H. Electronic health records to facilitate continuous detection of familial hypercholesterolemia Atherosclerosis 2020;310:83-87 [PubMed]
• Waissi Farahnaz, Dekker Mirthe, Timmerman Nathalie, Hoogeveen Renate M., van Bennekom Joelle, Dzobo Kim E., Schnitzler Johan G., Pasterkamp Gerard, Grobbee Diederick E., de Borst Gert J., Stroes Erik S. G., de Kleijn Dominique P. V., Kroon Jeffrey Elevated Lp(a) (Lipoprotein[a]) Levels Increase Risk of 30-Day Major Adverse Cardiovascular Events in Patients Following Carotid Endarterectomy Stroke; a journal of cerebral circulation 2020;51 (10):2972-2982 [PubMed]
• Rosenson Robert S., Burgess Lesley J., Ebenbichler Christoph F., Baum Seth J., Stroes Erik S.G., Ali Shazia, Khilla Nagwa, Hamlin Robert, Pordy Robert, Dong Yuping, Son Vladimir, Gaudet Daniel Evinacumab in patients with refractory hypercholesterolemia New England journal of medicine 2020;383 (24):2307-2319 [PubMed]
• Tromp Tycho R., Stroes Erik S. G., Hovingh G. Kees Gene-based therapy in lipid management: the winding road from promise to practice Expert opinion on investigational drugs 2020;29 (5):483-493 [PubMed]
• van den Boogert Marjolein A. W. Glycosylation defects in lipid metabolism 2020. 178p. ISBN 9789463809269. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes Erik S. G., Lefeber D. J.; Co-supervisors: Holleboom Adriaan G., Dallinga-Thie Geesje M.)
• Hoogeveen Renate M, Pereira João P Belo, Nurmohamed Nick S, Zampoleri Veronica, Bom Michiel J, Baragetti Andrea, Boekholdt S Matthijs, Knaapen Paul, Khaw Kay-Tee, Wareham Nicholas J, Groen Albert K, Catapano Alberico L, Koenig Wolfgang, Levin Evgeni, Stroes Erik S G Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention European heart journal 2020;41 (41):3998-4007 [PubMed]
• Poels Kikkie, Schnitzler Johan G., Waissi Farahnaz, Levels Johannes H. M., Stroes Erik S. G., Daemen Mat J. A. P., Lutgens Esther, Pennekamp Anne-Marije, de Kleijn Dominique P. V., Seijkens Tom T. P., Kroon Jeffrey Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability Frontiers in cell and developmental biology 2020;8 [PubMed]
• Moriarty Patrick M., Gorby Lauryn K., Stroes Erik S., Kastelein John P., Davidson Michael, Tsimikas Sotirios Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis Current atherosclerosis reports 2020;22 (9) [PubMed]
• Tsimikas Sotirios, Karwatowska-Prokopczuk Ewa, Gouni-Berthold Ioanna, Tardif Jean-Claude, Baum Seth J., Steinhagen-Thiessen Elizabeth, Shapiro Michael D., Stroes Erik S., Moriarty Patrick M., Nordestgaard B. rge G., Xia Shuting, Guerriero Jonathan, Viney Nicholas J., O'Dea Louis, Witztum Joseph L., Gouni-Berthold Ioanna, Tardif Jean-Claude, Baum Seth, Steinhagen-Thiessen Elizabeth, Shapiro Michael, Stroes Erik, Moriarty Patrick, Nordestgaard B. rge, Gaudet Daniel, Cuchel Marina, Maron David, Khandelwal Abha, Klausen Ib Christian, Rosenson Robert, DeMaria Anthony, Butman Samuel, Weintraub Howard, McPherson Ruth, Koren Michael, Bergeron Jean, Ballantyne Christie, DeFranco Anthony, Aspry Karen, Ahmed Haitham, Andersen Rolf, Hemphill Linda, Shah Prediman Krishan, Miller Michael, Strader Russell, Myerson Merle, Thanassoulis George Lipoprotein(a) Reduction in Persons with Cardiovascular Disease New England journal of medicine 2020;382 (3):244-255 [PubMed]
• Pereira João, Stroes Erik S. G., Groen Albert K., Zwinderman Aeilko H., Levin Evgeni Manifold mixing for stacked regularizationin: Peggy Cellier, Kurt Driessens, editors. Machine Learning and Knowledge Discovery in Databases - International Workshops of ECML PKDD 2019, Proceedings. Springer; 2020. p. 444-452, ISBN 9783030438227
• Zhang Xiang, Stiekema Lotte C. A., Stroes Erik S. G., Groen Albert K. Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a) Lipids in health and disease 2020;19 (1):91 [PubMed]
• Lobatto Mark E., Binderup Tina, Robson Philip M., Giesen Luuk F. P., Calcagno Claudia, Witjes Julia, Fay Francois, Baxter Samantha, Wessel Chang Ho, Eldib Mootaz, Bini Jason, Carlin Sean D., Stroes Erik S. G., Storm Gert, Kjaer Andreas, Lewis Jason S., Reiner Thomas, Fayad Zahi A., Mulder Willem J. M., Pérez-Medina Carlos Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall Bioconjugate chemistry 2020;31 (2):360-368 [PubMed]
• Bruikman Caroline S., Vreeken Dianne, Hoogeveen Renate M., Bom Michiel J., Danad Ibrahim, Pinto-Sietsma Sara-Joan, van Zonneveld Anton Jan, Knaapen Paul, Hovingh G. Kees, Stroes Erik S. G., van Gils Janine M. Netrin-1 and the Grade of Atherosclerosis Are Inversely Correlated in Humans Arteriosclerosis, thrombosis, and vascular biology 2020;40 (2):462-472 [PubMed]
• Reeskamp Laurens F., Tromp Tycho R., Defesche Joep C., Grefhorst Aldo, Stroes Erik S. G., Hovingh G. Kees, Zuurbier Linda Next-generation sequencing to confirm clinical familial hypercholesterolemia European journal of preventive cardiology 2020 [PubMed]
• Zheng Kang H., Kaiser Yannick, van Olden Casper C., Santos Raul D., Dasseux Jean-Louis, Genest Jacques, Gaudet Daniel, Westerink Jan, Keyserling Constance, Verberne Hein J., Leitersdorf Eran, Hegele Robert A., Descamps Olivier S., Hopkins Paul, Nederveen Aart J., Stroes Erik S. G. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels Atherosclerosis 2020;311:13-19 [PubMed]
• de Groot Pieter F., Nikolic Tatjana, Imangaliyev Sultan, Bekkering Siroon, Duinkerken Gaby, Keij Fleur M., Herrema Hilde, Winkelmeijer Maaike, Kroon Jeffrey, Levin Evgeni, Hutten Barbara, Kemper Elles M., Simsek Suat, Levels Johannes H. M., van Hoorn Flora A., Bindraban Renuka, Berkvens Alicia, Dallinga-Thie Geesje M., Davids Mark, Holleman Frits, Hoekstra Joost B. L., Stroes Erik S. G., Netea Mihai, van Raalte Daniël H., Roep Bart O., Nieuwdorp Max Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial Diabetologia 2020;63 (3):597-610 [PubMed]
• Stiekema Lotte C. A., Prange Koen H. M., Hoogeveen Renate M., Verweij Simone L., Kroon Jeffrey, Schnitzler Johan G., Dzobo Kim E., Cupido Arjen J., Tsimikas Sotirios, Stroes Erik S. G., de Winther Menno P. J., Bahjat Mahnoush Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a) European heart journal 2020;41 (24):2262-2271 [PubMed]
• Hegele Robert A., Borén Jan, Ginsberg Henry N., Arca Marcello, Averna Maurizio, Binder Christoph J., Calabresi Laura, Chapman M. John, Cuchel Marina, von Eckardstein Arnold, Frikke-Schmidt Ruth, Gaudet Daniel, Hovingh G. Kees, Kronenberg Florian, Lütjohann Dieter, Parhofer Klaus G., Raal Frederick J., Ray Kausik K., Remaley Alan T., Stock Jane K., Stroes Erik S., Tokgözoğlu Lale, Catapano Alberico L. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement Lancet. Diabetes and endocrinology 2020;8 (1):50-67 [PubMed]
• Zheng Kang He H. Seeing is believing: Translational imaging approaches in cardiovascular disease 2020. 289p. ISBN 9789463759298. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes Erik S. G., Nederveen Aart J.; Co-supervisors: Coolen Bram F., Verberne Hein J.)
• Schnitzler Johan G., Poels Kikkie, Stiekema Lotte C. A., Yeang Calvin, Tsimikas Sotirios, Kroon Jeffrey, Stroes Erik S. G., Lutgens Esther, Seijkens Tom T. P. Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytes International journal of cardiology 2020;315:81-85 [PubMed]
• Reeskamp Laurens F., Tromp Tycho R., Huijgen Roeland, Stroes Erik S. G., Hovingh G. Kees, Grefhorst Aldo Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation Atherosclerosis 2020;315:68-75 [PubMed]
• Schnitzler Johan G., Dzobo Kim E., Nurmohamed Nick S., Stroes Erik S. G., Kroon Jeffrey Surmounting the endothelial barrier for delivery of drugs and imaging tracers Atherosclerosis 2020;315:93-101 [PubMed]
• van der Bel René, Verbree Jasper, Gurney-Champion Oliver J., van Osch Matthias J. P., Stroes Erik S. G., Nederveen Aart J., Krediet C. T. Paul Sympathetic activation by lower body negative pressure decreases kidney perfusion without inducing hypoxia in healthy humans Clinical autonomic research 2020;30 (2):149-156 [PubMed]
• Nurmohamed N. S., Dallinga–Thie G. M., Stroes E. S. G. Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia Expert review of cardiovascular therapy 2020;18 (6):355-361 [PubMed]
• Tsimikas Sotirios, Stroes Erik S. G. The dedicated “Lp(a) clinic”: A concept whose time has arrived? Atherosclerosis 2020;300:1-9 [PubMed]
• Reeskamp Laurens F., Tromp Tycho R., Stroes Erik S. G. The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease? Current opinion in lipidology 2020;31 (3):140-146 [PubMed]
• Ståhle Mia, Silvola Johanna M. U., Hellberg Sanna, de Vries Margreet, Quax Paul H. A., Kroon Jeffrey, Rinne Petteri, de Jong Alwin, Liljenbäck Heidi, Savisto Nina, Wickman Anna, Stroes Erik S. G., Ylä-Herttuala Seppo, Saukko Pekka, Abrahamsson Tommy, Pettersson Knut, Knuuti Juhani, Roivainen Anne, Saraste Antti Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Atherosclerotic Mice JACC. Basic to translational science 2020;5 (4):360-373 [PubMed]
• Stiekema Lotte C. A., Hovingh G. Kees, Stroes Erik S. G. The therapeutic age paradox coming to an end European heart journal 2020;41 (24):2259-2261 [PubMed]
• Gilijamse Pim W., Hartstra Annick V., Levin Evgeni, Wortelboer Koen, Serlie Mireille J., Ackermans Mariette T., Herrema Hilde, Nederveen Aart J., Imangaliyev Sultan, Aalvink Steven, Sommer Morton, Levels Han, Stroes Erik S. G., Groen Albert K., Kemper Marleen, de Vos Willem M., Nieuwdorp Max, Prodan Andrei Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome NPJ biofilms and microbiomes 2020;6 (1) [PubMed]

2019

• Verbeek Rutger, Oldoni Federico, Surendran R. Preethi, Zwinderman Ailko H., Khaw Kay T., Stroes Erik S. G., Wareham Nick J., Boekholdt S. Matthijs, Dallinga-Thie Geesje M. A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease risk Journal of clinical lipidology 2019;13 (3):492-501 [PubMed]
• Cohn Danny M., Zeerleder Sacha S., Meijers Joost C. M., Stroes Erik S. G., Levi Marcel Albumin plasma exchange for life-threatening angioedema with normal C1-inhibitor Journal of Allergy and Clinical Immunology: In Practice 2019;7 (4):1360-1361 [PubMed]
• Zheng Kang H., Arsenault Benoit J., Kaiser Yannick, Khaw Kay-Tee, Wareham Nicholas J., Stroes Erik S. G., Boekholdt S. Matthijs apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study Journal of the American Heart Association 2019;8 (16):e013020 [PubMed]
• Watts Gerald F., Stroes Eric S. G. Editorial: New targets, treatments and trials for preventing and reversing atherosclerosis: the paradox of choice Current opinion in lipidology 2019;30 (6):417-418 [PubMed]
• Goldberg Anne C., Leiter Lawrence A., Stroes Erik S. G., Baum Seth J., Hanselman Jeffrey C., Bloedon LeAnne T., Lalwani Narendra D., Patel Pragna M., Zhao Xin, Barton Duell P. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial JAMA 2019;322 (18):1780-1788 [PubMed]
• Cleophas Maartje C. P., Ratter Jacqueline M., Bekkering Siroon, Quintin Jessica, Schraa Kiki, Stroes Erik S., Netea Mihai G., Joosten Leo A. B. Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males Scientific reports 2019;9 (1) [PubMed]
• Laufs Ulrich, Banach Maciej, Mancini G. B. John, Gaudet Daniel, Bloedon LeAnne T., Sterling Lulu Ren, Kelly Stephanie, Stroes Erik S. G. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance Journal of the American Heart Association 2019;8 (7):e011662 [PubMed]
• Kastelein John J. P., Stroes Erik S. G. FISHing for the miracle of eicosapentaenoic acid New England journal of medicine 2019;380 (1):89-90 [PubMed]
• Pereira João, Groen Albert K., Stroes Erik S. G., Levin Evgeni Graph space embeddingin: Sarit Kraus, editors. Proceedings of the 28th International Joint Conference on Artificial Intelligence, IJCAI 2019. International Joint Conferences on Artificial Intelligence; 2019. p. 3253-3259
• Tuñón José, Badimón Lina, Bochaton-Piallat Marie-Luce, Cariou Bertrand, Daemen Mat J., Egido Jesus, Evans Paul C., Hoefer Imo E., Ketelhuth Daniel F. J., Lutgens Esther, Matter Christian M., Monaco Claudia, Steffens Sabine, Stroes Erik, Vindis C. cile, Weber Christian, Bäck Magnus Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology Cardiovascular research 2019;115 (1):10-19 [PubMed]
• Emans Teuntje W. Kidney oxygenation by telemetry 2019. 160p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Homan van der Heide J. J. , Stroes E. S. G.; Co-supervisors: Krediet C. T. P. , Joles J. A.)
• Zheng Kang H., Tsimikas Sotirios, Pawade Tania, Kroon Jeffrey, Jenkins William S. A., Doris Mhairi K., White Audrey C., Timmers Nyanza K. L. M., Hjortnaes Jesper, Rogers Maximillian A., Aikawa Elena, Arsenault Benoit J., Witztum Joseph L., Newby David E., Koschinsky Marlys L., Fayad Zahi A., Stroes Erik S. G., Boekholdt S. Matthijs, Dweck Marc R. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis Journal of the American College of Cardiology 2019;73 (17):2150-2162 [PubMed]
• O'Donoghue Michelle L., Fazio Sergio, Giugliano Robert P., Stroes Erik S. G., Kanevsky Estella, Gouni-Berthold Ioanna, Im KyungAh, Lira Pineda Armando, Wasserman Scott M., Češka Richard, Ezhov Marat V., Jukema J. Wouter, Jensen Henrik K., Tokgözoğlu S. Lale, Mach François, Huber Kurt, Sever Peter S., Keech Anthony C., Pedersen Terje R., Sabatine Marc S. Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Circulation 2019;139 (12):1483-1492 [PubMed]
• Verbeek Rutger Lp(a) and PCSK9: From concept to clinical practice 2019. 169p. ISBN 9789463756235. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Hovingh G. K. , Stroes E. S. G.; Co-supervisor: Boekholdt S. M.)
• van den Boogert Marjolein A. W., Larsen Lars E., Ali Lubna, Kuil Sacha D., Chong Patrick L. W., Loregger Anke, Kroon Jeffrey, Schnitzler Johan G., Schimmel Alinda W. M., Peter Jorge, Levels Johannes H. M., Steenbergen Gerry, Morava Eva, Dallinga-Thie Geesje M., Wevers Ron A., Kuivenhoven Jan Albert, Hand Nicholas J., Zelcer Noam, Rader Daniel J., Stroes Erik S. G., Lefeber Dirk J., Holleboom Adriaan G. N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression Circulation 2019;140 (4):280-292 [PubMed]
• Neidhart Michel, Pajak Agnieszka, Laskari Katerina, Riksen Niels P., Joosten Leo A. B., Netea Mihai G., Lutgens Esther, Stroes Eric S. G., Ciurea Adrian, Distler Oliver, Grigorian Mariam, Karouzakis Emmanuel Oligomeric S100A4 Is Associated With Monocyte Innate Immune Memory and Bypass of Tolerance to Subsequent Stimulation With Lipopolysaccharides Frontiers in immunology 2019;10:791 [PubMed]
• Bakker Guido J, Vanbellinghen Manon C, Scheithauer Torsten P, Verchere C Bruce, Stroes Erik S, Timmers Nyanza K L M, Herrema Hilde, Nieuwdorp Max, Verberne Hein J, van Raalte Daniël H Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls PLoS ONE 2019;14 (3):e0213202 [PubMed]
• Hoogeveen Renate M., Opstal Tjerk S. J., Kaiser Yannick, Stiekema Lotte C. A., Kroon Jeffrey, Knol Remco J. J., Bax Willem A., Verberne Hein J., Cornel Jan H., Stroes Erik S. G. PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers JACC. Cardiovascular imaging 2019;12 (12):2571-2573 [PubMed]
• Stiekema Lotte C. A., Stroes Erik S. G., Verweij Simone L., Kassahun Helina, Chen Lisa, Wasserman Scott M., Sabatine Marc S., Mani Venkatesh, Fayad Zahi A. Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment European heart journal 2019;40 (33):2775-2781 [PubMed]
• Chauvierre C. dric, Aid-Launais Rachida, Aerts Joël, Chaubet Frédéric, Maire Murielle, Chollet Lucas, Rolland Lydia, Bonafé Roberta, Rossi Silvia, Bussi Simona, Cabella Claudia, Dézsi Laszlo, Fülöp Tamas, Szebeni Janos, Chahid Youssef, Zheng Kang H., Stroes Erik S. G., le Guludec Dominique, Rouzet François, Letourneur Didier Pharmaceutical development and safety evaluation of a GMP-grade fucoidan for molecular diagnosis of cardiovascular diseases Marine Drugs 2019;17 (12) [PubMed]
• Zheng Kang H., Schoormans Jasper, Stiekema Lotte C. A., Calcagno Claudia, Cicha Iwona, Alexiou Christoph, Strijkers Gustav J., Nederveen Aart J., Stroes Erik S. G., Coolen Bram F. Plaque Permeability Assessed With DCE-MRI Associates With USPIO Uptake in Patients With Peripheral Artery Disease JACC. Cardiovascular imaging 2019;12 (10):2081-2083 [PubMed]
• Nicorescu Ioana, Dallinga Geesje M., de Winther Menno P. J., Stroes Erik S. G., Bahjat Mahnoush Potential epigenetic therapeutics for atherosclerosis treatment Atherosclerosis 2019;281:189-197 [PubMed]
• Bom Michiel J., Levin Evgeni, Driessen Roel S., Danad Ibrahim, Van Kuijk Cornelis C., van Rossum Albert C., Narula Jagat, Min James K., Leipsic Jonathon A., Belo Pereira João P., Taylor Charles A., Nieuwdorp Max, Raijmakers Pieter G., Koenig Wolfgang, Groen Albert K., Stroes Erik S.G., Knaapen Paul Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease EBioMedicine 2019;39:109-117 [PubMed]
• van den Boogert Marjolein A. W., Crunelle Cleo L., Ali Lubna, Larsen Lars E., Kuil Sacha D., Levels Johannes H. M., Schimmel Alinda W. M., Konstantopoulou Vassiliki, Guerin Maryse, Kuivenhoven Jan Albert, Dallinga-Thie Geesje M., Stroes Erik S. G., Lefeber Dirk J., Holleboom Adriaan G. Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations Journal of inherited metabolic disease 2019 [PubMed]
• Bekkering Siroon, Stiekema Lotte C. A., Bernelot Moens Sophie, Verweij Simone L., Novakovic Boris, Prange Koen, Versloot Miranda, Roeters van Lennep Jeanine E., Stunnenberg Henk, de Winther Menno, Stroes Erik S. G., Joosten Leo A. B., Netea Mihai G., Riksen Niels P. Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia Cell metabolism 2019;30 (1):1-2 [PubMed]
• Witztum J. L., Gaudet D., Freedman S. D., Alexander V. J., Digenio A., Williams K. R., Yang Q., Hughes S. G., Geary R. S., Arca M., Stroes E. S. G., Bergeron J., Soran H., Civeira F., Hemphill L., Tsimikas S., Blom D. J., O'Dea L., Bruckert E. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome New England journal of medicine 2019;381 (6):531-542 [PubMed]

2018

• Landmesser Ulf, Chapman M. John, Stock Jane K., Amarenco Pierre, Belch Jill J. F., Borén Jan, Farnier Michel, Ference Brian A., Gielen Stephan, Graham Ian, Grobbee Diederick E., Hovingh G. Kees, Lüscher Thomas F., Piepoli Massimo F., Ray Kausik K., Stroes Erik S., Wiklund Olov, Windecker Stephan, Zamorano Jose Luis, Pinto Fausto, Tokgözoglu Lale, Bax Jeroen J., Catapano Alberico L. 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia European heart journal 2018;39 (14):1131–1143 [PubMed]
• Hartgers Merel L., Besseling Joost, Stroes Erik S., Wittekoek Janneke, Rutten Joost H. W., de Graaf Jacqueline, Visseren Frank L. J., Imholz Ben P. M., Roeters van Lennep Jeanine E., Huijgen Roeland, Kastelein John J. P., Hovingh G. Kees Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy Journal of clinical lipidology 2018;12 (4):972-980.e1 [PubMed]
• Verbeek Rutger, Hoogeveen Renate M, Langsted Anne, Stiekema Lotte C A, Verweij Simone L, Hovingh G Kees, Wareham Nicholas J, Khaw Kay-Tee, Boekholdt S Matthijs, Nordestgaard Børge G, Stroes Erik S G Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting European heart journal 2018;39 (27):2589-2596 [PubMed]
• Verweij Simone L., Duivenvoorden Raphaël, Stiekema Lotte C. A., Nurmohamed Nick S., van der Valk Fleur M., Versloot Miranda, Verberne Hein J., Stroes Erik S. G., Nahrendorf Matthias, Bekkering Siroon, Bernelot Moens Sophie J. CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease Cardiovascular research 2018;114 (3):468-475 [PubMed]
• Moulin Philippe, Dufour Robert, Averna Maurizio, Arca Marcello, Cefalù Angelo B., Noto Davide, D'Erasmo Laura, di Costanzo Alessia, Marçais Christophe, Walther Luis Antonio Alvarez-Sala, Banach Maciej, Borén Jan, Cramb Robert, Gouni-Berthold Ioanna, Hughes Elizabeth, Johnson Colin, Pintó Xavier, Reiner Željko, van Lennep Jeanine Roeters, Soran Handrean, Stefanutti Claudia, Stroes Erik, Bruckert Eric Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score Data in brief 2018;21:1334-1336 [PubMed]
• van Poelgeest Eveline P., Dillingh Marlous R., de Kam Marieke, Malone Karen E., Kemper Marleen, Stroes Erik S. G., Burggraaf Jacobus, Moerland Matthijs Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia Journal of pharmacological and toxicological methods 2018;89:39-46 [PubMed]
• Westerterp Marit, Fotakis Panagiotis, Ouimet Mireille, Bochem Andrea E., Zhang Hanrui, Molusky Matthew M., Wang Wei, Abramowicz Sandra, la Bastide-van Gemert Sacha, Wang Nan, Welch Carrie L., Reilly Muredach P., Stroes Erik S., Moore Kathryn J., Tall Alan R. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis Circulation 2018;138 (9):898-912 [PubMed]
• Hegele Robert A., Berberich Amanda J., Ban Matthew R., Wang Jian, Digenio Andres, Alexander Veronica J., D'Erasmo Laura, Arca Marcello, Jones Alan, Bruckert Eric, Stroes Erik S., Bergeron Jean, Civeira Fernando, Witztum Joseph L., Gaudet Daniel Clinical and biochemical features of different molecular etiologies of familial chylomicronemia Journal of clinical lipidology 2018;12 (4):920-927.e4 [PubMed]
• Stroes Erik, Robinson Jennifer G., Raal Frederick J., Dufour Robert, Sullivan David, Kassahun Helina, Ma Yuhui, Wasserman Scott M., Koren Michael J. Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies Clinical cardiology 2018;41 (10):1328-1335 [PubMed]
• Verbeek Rutger, Boekholdt S. Matthijs, Luben Robert, Stroes Erik S. G., Khaw Kay-Tee, Hovingh G. Kees Effect of Long-Term Low Lipoproteins on Neurocognitive Function Journal of the American College of Cardiology 2018;72 (10):1176-1177 [PubMed]
• Smits Loek P., Kootte Ruud S., Levin Evgeni, Prodan Andrei, Fuentes Susana, Zoetendal Erwin G., Wang Zeneng, Levison Bruce S., Cleophas Maartje C. P., Kemper E. Marleen, Dallinga-Thie Geesje M., Groen Albert K., Joosten Leo A. B., Netea Mihai G., Stroes Erik S. G., de Vos Willem M., Hazen Stanley L., Nieuwdorp Max Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome Journal of the American Heart Association 2018;7 (7) [PubMed]
• Lameijer Marnix, Binderup Tina, van Leent Mandy M. T., Senders Max L., Fay Francois, Malkus Joost, Sanchez-Gaytan Brenda L., Teunissen Abraham J. P., Karakatsanis Nicolas, Robson Philip, Zhou Xianxiao, Ye Yuxiang, Wojtkiewicz Gregory, Tang Jun, Seijkens Tom T. P., Kroon Jeffrey, Stroes Erik S. G., Kjaer Andreas, Ochando Jordi, Reiner Thomas, Pérez-Medina Carlos, Calcagno Claudia, Fischer Edward A., Zhang Bin, Temel Ryan E., Swirski Filip K., Nahrendorf Matthias, Fayad Zahi A., Lutgens Esther, Mulder Willem J. M., Duivenvoorden Raphaël Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates Nature Biomedical Engineering 2018;2 (5):279-292 [PubMed]
• Verweij Simone L., de Ronde Maurice W. J., Verbeek Rutger, Boekholdt S. Matthijs, Planken R. Nils, Stroes Erik S. G., Pinto-Sietsma Sara-Joan Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease Journal of clinical lipidology 2018;12 (3):597-603.e1 [PubMed]
• Lameijer Marnix, Binderup Tina, van Leent Mandy M. T., Senders Max L., Fay Francois, Malkus Joost, Sanchez-Gaytan Brenda L., Teunissen Abraham J. P., Karakatsanis Nicolas, Robson Philip, Zhou Xianxiao, Ye Yuxiang, Wojtkiewicz Gregory, Tang Jun, Seijkens Tom T. P., Kroon Jeffrey, Stroes Erik S. G., Kjaer Andreas, Ochando Jordi, Reiner Thomas, Pérez-Medina Carlos, Calcagno Claudia, Fisher Edward A., Zhang Bin, Temel Ryan E., Swirski Filip K., Nahrendorf Matthias, Fayad Zahi A., Lutgens Esther, Mulder Willem J. M., Duivenvoorden Raphaël Erratum to: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates (Nature Biomedical Engineering, (2018), 2, 5, (279-292), 10.1038/s41551-018-0221-2) Nature Biomedical Engineering 2018;2 (8):623 [PubMed]
• Gazzola Katia, Snijder Marieke B., Hovingh G. Kees, Stroes Erik S. G., Peters Ron J. G., van den Born Bert-Jan H. Ethnic differences in plasma lipid levels in a large multiethnic cohort: The HELIUS study Journal of clinical lipidology 2018;12 (5):1217-1224.e1 [PubMed]
• Cicha Iwona, Chauvierre C. dric, Texier Isabelle, Cabella Claudia, Metselaar Josbert M., Szebeni J. nos, Dézsi L. szló, Alexiou Christoph, Rouzet François, Storm Gert, Stroes Erik, Bruce Donald, MacRitchie Neil, Maffia Pasquale, Letourneur Didier From design to the clinic: practical guidelines for translating cardiovascular nanomedicine Cardiovascular research 2018;114 (13):1714-1727 [PubMed]
• Udayappan Shantha D. Gut microbiota in relation to pathogenesis of obesity and type 2 diabetes 2018. 178p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisors: Dallinga-Thie G. M., Herrema H. J.)
• Moulin Philippe, Dufour Robert, Averna Maurizio, Arca Marcello, Cefalù Angelo B., Noto Davide, D'Erasmo Laura, di Costanzo Alessia, Marçais Christophe, Alvarez-Sala Walther Luis Antonio, Banach Maciej, Borén Jan, Cramb Robert, Gouni-Berthold Ioanna, Hughes Elizabeth, Johnson Colin, Pintó Xavier, Reiner Željko, van Lennep Jeanine Roeters, Soran Handrean, Stefanutti Claudia, Stroes Erik, Bruckert Eric Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” Atherosclerosis 2018;275:265-272 [PubMed]
• Kroon Jeffrey, Schaefer Antje, van Rijssel Jos, Hoogenboezem Mark, van Alphen Floris, Hordijk Peter, Stroes Erik S. G., Strömblad Staffan, van Rheenen Jacco, van Buul Jaap D. Inflammation-Sensitive Myosin-X Functionally Supports Leukocyte Extravasation by Cdc42-Mediated ICAM-1-Rich Endothelial Filopodia Formation Journal of immunology (Baltimore, Md. 2018;200 (5):1790-1801 [PubMed]
• Tuñón José, Bäck Magnus, Badimón Lina, Bochaton-Piallat Marie-Luce, Cariou Bertrand, Daemen Mat J., Egido Jesus, Evans Paul C., Francis Sheila E., Ketelhuth Daniel F. J., Lutgens Esther, Matter Christian M., Monaco Claudia, Steffens Sabine, Stroes Erik, Vindis C. cile, Weber Christian, Hoefer Imo E. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice European journal of preventive cardiology 2018;25 (9):948-955 [PubMed]
• Hoogeveen Renate M., Nahrendorf Matthias, Riksen Niels P., Netea Mihai G., de Winther Menno P. J., Lutgens Esther, Nordestgaard B. rge G., Neidhart Michel, Stroes Erik S. G., Catapano Alberico L., Bekkering Siroon Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases European heart journal 2018;39 (38):3521-3527 [PubMed]
• Landmesser Ulf, Chapman M. John, Stock Jane K., Amarenco Pierre, Belch Jill J.F., Borén Jan, Farnier Michel, Ference Brian A., Gielen Stephan, Graham Ian, Grobbee Diederick E., Hovingh G. Kees, Lüscher Thomas F., Piepoli Massimo F., Ray Kausik K., Stroes Erik S., Wiklund Olov, Windecker Stephan, Zamorano Jose Luis, Pinto Fausto, Tokgözoglu Lale, Bax Jeroen J., Catapano Alberico L. New prospects for PCSK9 inhibition? European heart journal 2018;39 (27):2600-2601 [PubMed]
• Graham Ian, Shear Chuck, de Graeff Pieter, Boulton Caroline, Catapano Alberico L., Stough Wendy Gattis, Carlsson Stefan C., de Backer Guy, Emmerich Joseph, Greenfeder Scott, Kim Albert M., Lautsch Dominik, Nguyen Tu, Nissen Steven E., Prasad Krishna, Ray Kausik, Robinson Jennifer G., Sasiela William J., Bruins Slot Karsten, Stroes Erik, Thuren Tom, van der Schueren Bart, Velkovski-Rouyer Maja, Wasserman Scott M., Wiklund Olov, Zouridakis Emmanouil New Strategies for the Development of Lipid Lowering Therapies to Reduce Cardiovascular Risk European heart journal. Cardiovascular pharmacotherapy 2018;4 (2):119–127 [PubMed]
• Stroes Erik S. G., Susekov Andrey V., de Bruin Tjerk W. A., Kvarnström Mats, Yang Hong, Davidson Michael H. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial Journal of clinical lipidology 2018;12 (2):321-330 [PubMed]
• De Francesco Davide, Verboeket Sebastiaan O, Underwood Jonathan, Bagkeris Emmanouil , Wit Ferdinand W, Mallon Patrick W G, Winston Alan, Reiss Peter, Sabin Caroline A, Study group members AMC , Reiss P. , Wit F. W. N. M., Kooij K. W., van Zoest R. A. , Verheij E. , Verboeket Sebastiaan O., Prins M. , Kootstra N. A., Harskamp-Holwerda A. M. , Maurer Irma, Mangas Ruiz M. M., Boeser-Nunnink B. D. M. , Geerlings S. E. , Goorhuis A. , Hovius J. W. R. , Nellen F. J. B. , van der Poll Tom, Prins J. M. , Wiersinga W. J. , van Vugt M. , de Bree G. J. , Postema P. G. , Bisschop P. H. L. T., Serlie M. J. M. , Dekker E. , van der Velde N. , Willemsen J. M. R., Vogt L. , Portegies P. , Schmand B. A. , Geurtsen G. J. , Verbraak F. D. , Visser I. , Nieuwkerk P. T. , Majoie C. B. L. M. , Caan M. W. A. , van Lunsen H. W. , van den Born B. J. H. , Stroes E. S. G. Patterns of co-occurring comorbidities in people living with HIV Open forum infectious diseases 2018;5 (11):ofy272 [PubMed]
• Stoekenbroek Robert M., Hartgers Merel L., Rutte Roger, de Wijer Douwe D., Stroes Erik S. G., Hovingh G. Kees PCSK9 inhibitors in clinical practice: Delivering on the promise? Atherosclerosis 2018;270 (March):205-210 [PubMed]
• Cho Leslie, Dent Ricardo, Stroes Erik S. G., Stein Evan A., Sullivan David, Ruzza Andrea, Flower Andrea, Somaratne Ransi, Rosenson Robert S. Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2018;32 (4):365-372 [PubMed]
• Verweij Simone L., Stiekema Lotte C. A., Delewi Ronak, Zheng Kang H., Bernelot Moens Sophie J., Kroon Jeffrey, Stroes Charlotte I., Versloot Miranda, Piek Jan J., Verberne Hein J., Stroes Erik S. G. Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT European journal of nuclear medicine and molecular imaging 2018;45 (11):1956-1963 [PubMed]
• van Capelleveen Julian C., Lee Sang-Rok, Verbeek Rutger, Kastelein John J. P., Wareham Nicholas J., Stroes Erik S. G., Hovingh G. Kees, Khaw Kay-Tee, Boekholdt S. Matthijs, Witztum Joseph L., Tsimikas Sotirios Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study Journal of clinical lipidology 2018;12 (6):1493-1501.e11 [PubMed]
• Vasamsetti Sathish Babu, Florentin Jonathan, Coppin Emilie, Stiekema Lotte C. A., Zheng Kang H., Nisar Muhammad Umer, Sembrat John, Levinthal David J., Rojas Mauricio, Stroes Erik S. G., Kim Kang, Dutta Partha Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation Immunity 2018;49 (1):93-106.e7 [PubMed]
• Verweij Simone L. The inflammable truth of atherosclerosis 2018. ISBN 9789463750011. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: Bernelot Moens S. J., Verberne H. J.)
• Kootte Ruud S. The role of the intestine in human glucose and lipid metabolism: Source for novel targets in the prevention of cardiometabolic disease 2018. ISBN 9789462339460. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisor: Dallinga-Thie G. M.)
• Watts Gerald F., Stroes Eric S. G. Writing on the wall for precision medicine in the prevention of atherosclerotic cardiovascular disease Current opinion in lipidology 2018;29 (6):433-435 [PubMed]

2017

• van Capelleveen Julian C., Bernelot Moens Sophie J., Yang Xiaohong, Kastelein John J. P., Wareham Nicholas J., Zwinderman Aeilko H., Stroes Erik S. G., Witztum Joseph L., Hovingh G. Kees, Khaw Kay-Tee, Boekholdt S. Matthijs, Tsimikas Sotirios Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study Arteriosclerosis, thrombosis, and vascular biology 2017;37 (6):1206-1212 [PubMed]
• Bernelot Moens Sophie J., Verweij Simone L., van der Valk Fleur M., van Capelleveen Julian C., Kroon Jeffrey, Versloot Miranda, Verberne Hein J., Marquering Henk A., Duivenvoorden Raphaël, Vogt Liffert, Stroes Erik S. G. Arterial and Cellular Inflammation in Patients with CKD Journal of the American Society of Nephrology 2017;28 (4):1278-1285 [PubMed]
• van der Bel René, Gurney-Champion Oliver J., Froeling Martijn, Stroes Erik S. G., Nederveen Aart J., Krediet C. T. Paul A tri-exponential model for intravoxel incoherent motion analysis of the human kidney: In silico and during pharmacological renal perfusion modulation European journal of radiology 2017;91:168-174 [PubMed]
• van der Bel René, Çalişkan Müşerref, van Hulst Robert A., van Lieshout Johannes J., Stroes Erik S. G., Krediet C. T. Paul Blood Pressure Increase during Oxygen Supplementation in Chronic Kidney Disease Patients Is Mediated by Vasoconstriction Independent of Baroreflex Function Frontiers in physiology 2017;8 [PubMed]
• Stroes Erik, Moulin Philippe, Parhofer Klaus G., Rebours Vinciane, Löhr J.-Matthias, Averna Maurizio Diagnostic algorithm for familial chylomicronemia syndrome Atherosclerosis. Supplements 2017;23:1-7 [PubMed]
• Smits Loek P., Tiessens Feiko, Zheng Kang He, Stroes Erik S., Nederveen Aart J., Coolen Bram F. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation Atherosclerosis 2017;263:211-218 [PubMed]
• Stoekenbroek Robert M., Lokin Joost L. C., Nielen Mark M., Stroes Erik S. G., Koelemay Mark J. W. How common are foot problems among individuals with diabetes? Diabetic foot ulcers in the Dutch population Diabetologia 2017;60 (7):1271-1275 [PubMed]
• Averna Maurizio, Stroes Erik, Ogura Masatsune, Postadzhiyan Arman, Cercek Miha, Calabrò Paolo, Suppressa Patrizia How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL Atherosclerosis. Supplements 2017;26:16-24 [PubMed]
• Rosenson Robert S., Gandra Shravanthi R., McKendrick Jan, Dent Ricardo, Wieffer Heather, Cheng Lung-I., Catapano Alberico L., Oh Paul, Kees Hovingh G., Stroes Erik S. Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2017;31 (2):187-195 [PubMed]
• van Capelleveen Julian C. Identification and targeting of genes in atherosclerosis 2017. 342p. ISBN 9789462997585. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Hovingh G. K.; Co-supervisor: Dallinga-Thie G. M.)
• Kootte Ruud S., Levin Evgeni, Salojärvi Jarkko, Smits Loek P., Hartstra Annick V., Udayappan Shanti D., Hermes Gerben, Bouter Kristien E., Koopen Annefleur M., Holst Jens J., Knop Filip K., Blaak Ellen E., Zhao Jing, Smidt Hauke, Harms Amy C., Hankemeijer Thomas, Bergman Jacques J. G. H. M., Romijn Hans A., Schaap Frank G., Olde Damink Steven W. M., Ackermans Mariette T., Dallinga-Thie Geesje M., Zoetendal Erwin, de Vos Willem M., Serlie Mireille J., Stroes Erik S. G., Groen Albert K., Nieuwdorp Max Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition Cell metabolism 2017;26 (4):611-619-e6 [PubMed]
• van der Valk Fleur M., Kuijk Carlijn, Verweij Simone L., Stiekema Lotte C. A., Kaiser Y., Zeerleder Sacha, Nahrendorf Matthias, Voermans Carlijn, Stroes Erik S. G. Increased haematopoietic activity in patients with atherosclerosis European heart journal 2017;38 (6):425-432 [PubMed]
• Udayappan Shanthadevi D., Kovatcheva-Datchary Petia, Bakker Guido J., Havik Stefan R., Herrema Hilde, Cani Patrice D., Bouter Kristien E., Belzer Clara, Witjes Julia J., Vrieze Anne, de Sonnaville Noor, Chaplin Alice, van Raalte Daniel H., Aalvink Steven, Dallinga-Thie Geesje M., Heilig Hans G. H. J., Bergström Göran, van der Meij Suzan, van Wagensveld Bart A., Hoekstra Joost B. L., Holleman Frits, Stroes Erik S. G., Groen Albert K., Bäckhed Fredrik, de Vos Willem M., Nieuwdorp Max Intestinal Ralstonia pickettii augments glucose intolerance in obesity PLoS ONE 2017;12 (11) [PubMed]
• van der Bel René Kidney oxygenation under pressure 2017. 151p. ISBN 9789462997370. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Homan van der Heide J. J.; Co-supervisors: Krediet C. T. P., Nederveen A. J.)
• Gencer Baris, Kronenberg Florian, Stroes Erik S., Mach François Lipoprotein(a): the revenant European heart journal 2017;38 (20):1553-1560 [PubMed]
• Schnitzler Johan G., Bernelot Moens Sophie J., Tiessens Feiko, Bakker Guido J., Dallinga-Thie Geesje M., Groen Albert K., Nieuwdorp Max, Stroes Erik S. G., Kroon Jeffrey Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient- derived circulating monocytes using confocal microscopy Journal of lipid research 2017;58 (11):2210-2219 [PubMed]
• Rosenson Robert S., Baker Steven, Banach Maciej, Borow Kenneth M., Braun Lynne T., Bruckert Eric, Brunham Liam R., Catapano Alberico L., Elam Marshall B., Mancini G. B. John, Moriarty Patrick M., Morris Pamela B., Muntner Paul, Ray Kausik K., Stroes Erik S., Taylor Beth A., Taylor Valerie H., Watts Gerald F., Thompson Paul D. Optimizing Cholesterol Treatment in Patients With Muscle Complaints Journal of the American College of Cardiology 2017;70 (10):1290-1301 [PubMed]
• Bernelot Moens Sophie J., Neele Annette E., Kroon Jeffrey, van der Valk Fleur M., van den Bossche Jan, Hoeksema Marten A., Hoogeveen Renate M., Schnitzler Johan G., Baccara-Dinet Marie T., Manvelian Garen, de Winther Menno P. J., Stroes Erik S. G. PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia European heart journal 2017;38 (20):1584-1593 [PubMed]
• Bernelot Moens Sophie J., Verweij Simone L., Schnitzler Johan G., Stiekema Lotte C. A., Bos Merijn, Langsted Anne, Kuijk Carlijn, Bekkering Siroon, Voermans Carlijn, Verberne Hein J., Nordestgaard Børge G., Stroes Erik S. G., Kroon Jeffrey Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans Arteriosclerosis, thrombosis, and vascular biology 2017;37 (5):969-975 [PubMed]
• Toth Peter P., Worthy Gillian, Gandra Shravanthi R., Sattar Naveed, Bray Sarah, Cheng Lung-I., Bridges Ian, Worth Gavin M., Dent Ricardo, Forbes Carol A., Deshpande Sohan, Ross Janine, Kleijnen Jos, Stroes Erik S. G. Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia Journal of the American Heart Association 2017;6 (10) [PubMed]
• Stiekema Lotte C. A., Schnitzler Johan G., Nahrendorf Matthias, Stroes Erik S. G. The maturation of a "neural-hematopoietic' inflammatory axis in cardiovascular disease Current opinion in lipidology 2017;28 (6):507-512 [PubMed]
• Steinhagen-Thiessen Elisabeth, Stroes Erik, Soran Handrean, Johnson Colin, Moulin Philippe, Iotti Giorgio, Zibellini Marco, Ossenkoppele Bas, Dippel Michaela, Averna Maurizio R. The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency Atherosclerosis 2017;262:146-153 [PubMed]
• Watts Gerald F., Stroes Erik S. G. The shape of things to come in lipid management: a feast of reason Current opinion in lipidology 2017;28 (6):449-451 [PubMed]
• Eeftinck Schattenkerk Daan W. Towards personalized antihypertensive therapy: innovate or denervate? 2017. 228p. ISBN 9789462995352. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Reekers J. A.; Co-supervisors: van den Born B. J. H., Vogt L.)
• Hovingh G. Kees, Boekholdt S. Matthijs, Stroes Erik S. Very low LDL-cholesterol concentrations achieved: which target is next? Lancet 2017;390 (10106):1930-1931 [PubMed]

2016

• Viney Nicholas J., van Capelleveen Julian C., Geary Richard S., Xia Shuting, Tami Joseph A., Yu Rosie Z., Marcovina Santica M., Hughes Steven G., Graham Mark J., Crooke Rosanne M., Crooke Stanley T., Witztum Joseph L., Stroes Erik S., Tsimikas Sotirios Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials Lancet 2016;388 (10057):2239-2253 [PubMed]
• Bernelot Moens Sophie J. Cardiovascular disease beyond traditional risk factors: Balancing lipids and inflammation 2016. 253p. ISBN 9789462334588. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisor: Dallinga-Thie G. M.)
• Bernelot Moens Sophie J., Stoekenbroek Robert M., van der Valk Fleur M., Verweij Simone L., Koelemay Mark J. W., Verberne Hein J., Nieuwdorp Max, Stroes Erik S. G. Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study BMC cardiovascular disorders 2016;16 (1):237 [PubMed]
• Kooij Katherine W., Wit Ferdinand W. N. M., Booiman Thijs, van der Valk Marc, Schim van der Loeff Maarten F., Kootstra Neeltje A., Reiss Peter, Schouten J., van Zoest R. A., Verheij E., Elsenga B. C., Prins M., Martens M., Moll S., Berkel J., Totté M., Visser G. R., May L., Kovalev S., Newsum A., Boeser-Nunnink B., Geerlings S. E., Godfried M. H., Goorhuis A., Hovius J. W. R., van der Meer J. T. M., Nellen F. J. B., van der Poll T., Prins J. M., Wiersinga W. J., van Vugt M., Postema P. G., Bisschop P. H. L. T., Serlie M. J. M., Dekker E., van der Velde N., Vogt L., Portegies P., Schmand B. A., Geurtsen G. J., Verbraak F. D., Demirkaya N., Nieuwkerk P. T., Langebeek N., van Steenwijk R. P., Majoie C. B. L. M., Caan M. W. A., van Lunsen H. W., van den Born B. J. H., Stroes E. S. G. Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals Journal of infectious diseases 2016;214 (12):1817-1821 [PubMed]
• Cho Leslie, Rocco Michael, Colquhoun David, Sullivan David, Rosenson Robert S., Dent Ricardo, Xue Allen, Scott Rob, Wasserman Scott M., Stroes Erik Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2016;30 (3):297-304 [PubMed]
• Nissen Steven E., Dent-Acosta Ricardo E., Rosenson Robert S., Stroes Erik, Sattar Naveed, Preiss David, Mancini G. B. John, Ballantyne Christie M., Catapano Alberico, Gouni-Berthold Ioanna, Stein Evan A., Xue Allen, Wasserman Scott M., Scott Rob, Thompson Paul D., Sullivan David, Lehman Sam, Kostner Karam, Wauchope Andrew Don, Hartleib Michael, Baass Alexis, Bergeron Jean, Joy Karam, Ceska Richard, Adamkova Vera, Blaha Vladimir, Jeppesen Jorgen, Jensen Henrik Kjaerulf, Bruckert Eric, Krempf Michel, Bully Chantal, Bosiljanoff Peter, Steinhagen-Thiessen Elisabeth, Pintus Paolo, Borghi Claudio, Sampietro Tiziana, Vigna Giovanni Battista, Mannarino Elmo, Pozzi Claudio, Liem Anho, van Leendert Rudolf, Scott Russell, Kjaernli Thorbjorn, Langslet Gisle, Jacovides Andrew, Klug Eric, Blom Dirk, Neely Dermot, Dawson Charlotte, Miller Michael Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial Clinical cardiology 2016;39 (3):137-144 [PubMed]
• Mulders Ties A., Taraboanta Catalin, Franken Lotte C., van Heel Eddy, Klass Gunter, Forster Bruce B., Arad Yadon, Boekholdt S. Matthijs, Groenink Maarten, Fröhlich Jiri, Guerci Alan D., Stroes Erik S. G., Pinto-Sietsma Sara-Joan Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease Atherosclerosis 2016;245:155-160 [PubMed]
• van Wijk Diederik F., Boekholdt S. Matthijs, Arsenault Benoit J., Ahmadi-Abhari Sara, Wareham Nicholas J., Stroes Erik S. G., Khaw Kay-Tee C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study Journal of the American Heart Association 2016;5 (6):e002823 [PubMed]
• van Capelleveen Julian C., van der Valk Fleur M., Stroes Erik S. G. Current therapies for lowering lipoprotein (a) Journal of lipid research 2016;57 (9):1612-1618 [PubMed]
• Schouten Judith, Su Tanja, Wit Ferdinand W., Kootstra Neeltje A., Caan Matthan W. A., Geurtsen Gert J., Schmand Ben A., Stolte Ineke G., Prins Maria, Majoie Charles B., Portegies Peter, Reiss Peter, van der Valk M., Kooij K. W., van Zoest R. A., Elsenga B. C., Prins M., Stolte I. G., Martens M., Moll S., Berkel J., Möller L., Visser G. R., Gras L. A. J., van Leeuwen E., Geerlings S. E., Godfried M. H., Goorhuis A., van der Meer J. T. M., Nellen F. J. B., van der Poll T., Prins J. M., Wiersinga W. J., Postema P. G., Bisschop P. H. L. T., Serlie M. J. M., Dekker E., de Rooij S. E. J. A., Vogt L., van Eck-Smit B. L. F., de Jong M., Richel D. J., Verbraak F. D., Demirkaya N., Ruhé H. G., Nieuwkerk P. T., van Steenwijk R. P., van Lunsen H. W., van den Born B. J. H., Stroes E. S. G. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy AIDS (London, England) 2016;30 (7):1027-1038 [PubMed]
• Stroes Erik, Guyton John R., Lepor Norman, Civeira Fernando, Gaudet Daniel, Watts Gerald F., Baccara-Dinet Marie T., Lecorps Guillaume, Manvelian Garen, Farnier Michel, Kostner K., Lehman S., Descamps O., Gheyle L., Mathieu C., Bergeron J., Elliott T., Girard G., Gupta A., Hoag G., Hove J., Jeppesen J., Kjærulf J. H., Klarlund K., Thomsen K. K., Basart D. C. G., Kooy A., Liem A., Swart H., Troquay R., van Het Hof-Wiersma J., Viergever P., Visseren F., Doughty R. N., Scott R., Calvo C., Díaz-Díaz J. L., Fuentes F., Gil-Extremera B., Jericó C., Matas Pericas L., Mediavilla Garcia J. D., Bolster D. E., Koren M., El Shahawy M., Vardi G., Weinstein D., Zuzarte K., Ginsberg Henry, Kastelein John J. P. Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study Journal of the American Heart Association 2016;5 (9):e003421 [PubMed]
• Ginsberg Henry N., Rader Daniel J., Raal Frederick J., Guyton John R., Baccara-Dinet Marie T., Lorenzato Christelle, Pordy Robert, Stroes Erik Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2016;30 (5):473-483 [PubMed]
• Bernelot Moens Sophie J., van der Valk Fleur M., Strang Aart C., Kroon Jeffrey, Smits Loek P., Kneepkens Eva L., Verberne Hein J., van Buul Jaap D., Nurmohamed Michael T., Stroes Erik S. G. Erratum to: Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study Arthritis research & therapy 2016;18 (1):298 [PubMed]
• Lobatto Mark E. Exploration and application of nanomedicine in atherosclerotic disease 2016. 249p. ISBN 9789462954243. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Mulder W. J. M., Stroes E. S. G.; Co-supervisor: Metselaar J. M.)
• Zheng Kang H., Stroes Erik S. G. HDL infusion for the management of atherosclerosis: current developments and new directions Current opinion in lipidology 2016;27 (6):592-596 [PubMed]
• Zheng Kang He, van der Valk Fleur M., Smits Loek P., Sandberg Mara, Dasseux Jean-Louis, Baron Rudi, Barbaras Ronald, Keyserling Constance, Coolen Bram F., Nederveen Aart J., Verberne Hein J., Nell Thijs E., Vugts Danielle J., Duivenvoorden Raphaël, Fayad Zahi A., Mulder Willem J. M., van Dongen Guus A. M. S., Stroes Erik S. G. HDL mimetic CER-001 targets atherosclerotic plaques in patients Atherosclerosis 2016;251:381-388 [PubMed]
• Demirkaya Nazli, Wit Ferdinand W. N. M., van den Berg Thomas J. T. P., Kooij Katherine W., Prins Maria, Schlingemann Reinier O., Abramoff Michael D., Reiss Peter, Verbraak Frank D., van der Valk M., Schouten J. [=Judith], van Zoest R. A., Elsenga B. C., Martens M., Moll S., Berkel J., Totté M., Visser G. R., Kovalev S., Kootstra N. A., van Leeuwen E., Geerlings S. E., Godfried M. H., Goorhuis A., Hovius J. W. R., van der Meer J. T. M., Nellen F. J. B., van der Poll T., Prins J. M., Wiersinga W. J., Postema P. G., Bisschop P. H. L. T., Serlie M. J. M., Dekker E., de Rooij S. E. J. A., Vogt L., Portegies P., Schmand B. A., Geurtsen G. J., van Eck-Smit B. L. F., de Jong M., Richel D. J., Ruhé H. G., Nieuwkerk P. T., van Steenwijk R. P., Majoie C. B. L. M., Caan M. W. A., van Lunsen H. W., van den Born B. J. H., Stroes E. S. G. HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study Investigative ophthalmology & visual science 2016;57 (3):1388-1397 [PubMed]
• Hovingh G. Kees, Gandra Shravanthi R., McKendrick Jan, Dent Ricardo, Wieffer Heather, Catapano Alberico L., Oh Paul, Rosenson Robert S., Stroes Erik S. Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey Atherosclerosis 2016;245:111-117 [PubMed]
• Bernelot Moens Sophie J., van Leuven Sander I., Zheng Kang H., Havik Stefan R., Versloot Miranda V., van Duivenvoorde Leonie M., Hahne Michael, Stroes Erik S. G., Baeten Dominique L., Hamers Anouk A. J. Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques PLoS ONE 2016;11 (11):e0164690 [PubMed]
• van der Valk Fleur M., Bernelot Moens Sophie J., Verweij Simone L., Strang Aart C., Nederveen Aart J., Verberne Hein J., Nurmohamed Michael T., Baeten Dominique L., Stroes Erik S. G. Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy Annals of the rheumatic diseases 2016;75 (10):1848-1851 [PubMed]
• Pérez-Medina Carlos, Binderup Tina, Lobatto Mark E., Tang Jun, Calcagno Claudia, Giesen Luuk, Wessel Chang Ho, Witjes Julia, Ishino Seigo, Baxter Samantha, Zhao Yiming, Ramachandran Sarayu, Eldib Mootaz, Sánchez-Gaytán Brenda L., Robson Philip M., Bini Jason, Granada Juan F., Fish Kenneth M., Stroes Erik S. G., Duivenvoorden Raphaël, Tsimikas Sotirios, Lewis Jason S., Reiner Thomas, Fuster Valentín, Kjær Andreas, Fisher Edward A., Fayad Zahi A., Mulder Willem J. M. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models JACC. Cardiovascular imaging 2016;9 (8):950-961 [PubMed]
• van der Valk Fleur M., Schulte Dominik M., Meiler Svenja, Tang Jun, Zheng Kang He, van den Bossche Jan, Seijkens Tom, Laudes Matthias, de Winther Menno, Lutgens Esther, Alaarg Amr, Metselaar Josbert M., Dallinga-Thie Geesje M., Mulder Willem J. M., Stroes Erik S. G., Hamers Anouk A. J. Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis Nanomedicine: nanotechnology, biology and medicine 2016;12 (6):1463-1470 [PubMed]
• Gaudet Daniel, Stroes Erik S., Méthot Julie, Brisson Diane, Tremblay Karine, Bernelot Moens Sophie J., Iotti Giorgio, Rastelletti Irene, Ardigo Diego, Corzo Deyanira, Meyer Christian, Andersen Marc, Ruszniewski Philippe, Deakin Mark, Bruno Marco J. Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis Human gene therapy 2016;27 (11):916-925 [PubMed]
• van der Bel René, Coolen Bram F., Nederveen Aart J., Potters Wouter V., Verberne Hein J., Vogt Liffert, Stroes Erik S. G., Krediet C. T. Paul Magnetic Resonance Imaging-Derived Renal Oxygenation and Perfusion During Continuous, Steady-State Angiotensin-II Infusion in Healthy Humans Journal of the American Heart Association 2016;5 (3):e003185 [PubMed]
• Smits Loek P., van Wijk Diederik F., Duivenvoorden Raphael, Xu Dongxiang, Yuan Chun, Stroes Erik S., Nederveen Aart J. Manual versus Automated Carotid Artery Plaque Component Segmentation in High and Lower Quality 3.0 Tesla MRI Scans PLoS ONE 2016;11 (12):e0164267 [PubMed]
• Alaarg Amr, Zheng Kang He, van der Valk Fleur M., da Silva Acarilia Eduardo, Versloot Miranda, van Ufford Linda C. Quarles, Schulte Dominik M., Storm Gert, Metselaar Josbert M., Stroes Erik S. G., Hamers Anouk A. J. Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques Vascular pharmacology 2016;82:51-59 [PubMed]
• Smits Loek P., Coolen Bram F., Panno Maria D., Runge Jurgen H., Nijhof Wouter H., Verheij Joanne, Nieuwdorp Max, Stoker Jaap, Beuers Ulrich H., Nederveen Aart J., Stroes Erik S. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study Radiology 2016;278 (3):782-791 [PubMed]
• Udayappan Shanthadevi, Manneras-Holm Louise, Chaplin-Scott Alice, Belzer Clara, Herrema Hilde, Dallinga-Thie Geesje M., Duncan Silvia H., Stroes Erik S. G., Groen Albert K., Flint Harry J., Backhed Fredrik, de Vos Willem M., Nieuwdorp Max Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice NPJ biofilms and microbiomes 2016;2:16009 [PubMed]
• van der Valk Fleur M., Bekkering Siroon, Kroon Jeffrey, Yeang Calvin, van den Bossche Jan, van Buul Jaap D., Ravandi Amir, Nederveen Aart J., Verberne Hein J., Scipione Corey, Nieuwdorp Max, Joosten Leo A. B., Netea Mihai G., Koschinsky Marlys L., Witztum Joseph L., Tsimikas Sotirios, Riksen Niels P., Stroes Erik S. G. Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans Circulation 2016;134 (8):611-624 [PubMed]
• Rodrigues Rute, Artieda Marta, Tejedor Diego, Martínez Antonio, Konstantinova Pavlina, Petry Harald, Meyer Christian, Corzo Deyanira, Sundgreen Claus, Klor Hans U., Gouni-Berthold Ioanna, Westphal Sabine, Steinhagen-Thiessen Elisabeth, Julius Ulrich, Winkler Karl, Stroes Erik, Vogt Anja, Hardt Phillip, Prophet Heinrich, Otte Britta, Nordestgaard Borge G., Deeb Samir S., Brunzell John D. Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency Journal of clinical lipidology 2016;10 (2):394-409 [PubMed]
• van der Hoeven Niels V. Reliability of blood pressure measurement and cardiovascular risk prediction 2016. 179p. ISBN 9789462333246. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: van den Born B. J. H., Kraaijenhagen R. A.)
• Cobos Jiménez Viviana, Wit Ferdinand W. N. M., Joerink Maaike, Maurer Irma, Harskamp Agnes M., Schouten Judith, Prins Maria, van Leeuwen Ester M. M., Booiman Thijs, Deeks Steven G., Reiss Peter, Kootstra Neeltje A., van der Valk M., Kooij K. W., van Zoest R. A., Elsenga B. C., Prins M., Martens M., Boeser-Nunnink B., Geerlings S. E., Godfried M. H., Goorhuis A., Hovius J. W. R., Nellen F. J. B., van der Meer J. T. M., van der Poll T., Prins J. M., Wiersinga W. J., Postema P. G., Bisschop P. H. L. T., Serlie M. J. M., Dekker E., de Rooij S. E. J. A., Vogt L., Portegies P., Schmand B. A., Geurtsen G. J., van Eck-Smit B. L. F., de Jong M., Richel D. J., Verbraak F. D., Demirkaya N., Ruhé H. G., Nieuwkerk P. T., van Steenwijk R. P., Majoie C. B. L. M., Caan M. W. A., van Lunsen H. W., van den Born B. J. H., Stroes E. S. G. T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment Journal of infectious diseases 2016;214 (2):216-225 [PubMed]
• van der Valk Fleur M., Verweij Simone L., Zwinderman Koos A. H., Strang Aart C., Kaiser Yannick, Marquering Henk A., Nederveen Aart J., Stroes Erik S. G., Verberne Hein J., Rudd James H. F. Thresholds for Arterial Wall Inflammation Quantified by (18)F-FDG PET Imaging: Implications for Vascular Interventional Studies JACC. Cardiovascular imaging 2016;9 (10):1198-1207 [PubMed]
• Jakulj Lily, van Dijk Theo H., de Boer Jan Freark, Kootte Ruud S., Schonewille Marleen, Paalvast Yared, Boer Theo, Bloks Vincent W., Boverhof Renze, Nieuwdorp Max, Beuers Ulrich H. W., Stroes Erik S. G., Groen Albert K. Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion Cell metabolism 2016;24 (6):783-794 [PubMed]
• van der Valk Fleur Translating lipid-driven infammation in atherosclerosis 2016. 273p. ISBN 9789462994188. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Nieuwdorp M.; Co-supervisor: Nederveen A. J.)
• Bernelot Moens Sophie J., van der Valk Fleur M., Strang Aart C., Kroon Jeffrey, Smits Loek P., Kneepkens Eva L., Verberne Hein J., van Buul Jaap D., Nurmohamed Michael T., Stroes Erik S. G. Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study Arthritis research & therapy 2016;18 (1):115 [PubMed]

2015

• Stoekenbroek R. M., Stroes E. S., Hovingh G. K. ApoA-I mimetics Handbook of experimental pharmacology 2015;224:631-648 [PubMed]
• Stroes Erik S., van der Valk Fleur M. A sense of excitement for a specific Lp(a)-lowering therapy Lancet 2015;386 (10002):1427-1429 [PubMed]
• van der Hoeven Niels V., Niessen Maurice A. J., Stroes Erik S. G., Burdorf Lex, Kraaijenhagen Roderik A., van den Born Bert-Jan H. A six question screen to facilitate primary cardiovascular disease prevention BMC cardiovascular disorders 2015;15 (1):140 [PubMed]
• Lobatto Mark E., Calcagno Claudia, Millon Antoine, Senders Max L., Fay Francois, Robson Philip M., Ramachandran Sarayu, Binderup Tina, Paridaans Maarten P. M., Sensarn Steven, Rogalla Stephan, Gordon Ronald E., Cardoso Luis, Storm Gert, Metselaar Josbert M., Contag Christopher H., Stroes Erik S. G., Fayad Zahi A., Mulder Willem J. M. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging ACS nano 2015;9 (2):1837-1847 [PubMed]
• Strang Aart C., Knetsch Menno L. W., Koole Leo H., de Winter Robbert J., van der Wal Allard C., de Vries Carlie J. M., Tak Paul P., Bisoendial Radjesh J., Stroes Erik S. G., Rotmans Joris I. Effect of anti-ApoA-I antibody-coating of stents on neointima formation in a rabbit balloon-injury model PLoS ONE 2015;10 (3):e0122836 [PubMed]
• Kootte Ruud S., Smits Loek P., van der Valk Fleur M., Dasseux Jean-Louis, Keyserling Constance H., Barbaras Ronald, Paolini John F., Santos Raul D., van Dijk Theo H., Dallinga-van Thie Geesje M., Nederveen Aart J., Mulder Willem J. M., Hovingh G. Kees, Kastelein John J. P., Groen Albert K., Stroes Erik S. Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA Journal of lipid research 2015;56 (3):703-712 [PubMed]
• Robinson Jennifer G., Farnier Michel, Krempf Michel, Bergeron Jean, Luc Gérald, Averna Maurizio, Stroes Erik S., Langslet Gisle, Raal Frederick J., El Shahawy Mahfouz, Koren Michael J., Lepor Norman E., Lorenzato Christelle, Pordy Robert, Chaudhari Umesh, Kastelein John J. P., Caccavo Alberto, Codutti Oscar, Gelersztein Elisabeth, Vico Marisa, Zaidman Cesar, Majul Claudio, Balthazar Yohan, Capiau Luc, Vrolix Mathias, Vermeersch Paul, Gotchev Dobromir, Todorov Georgi, Tumbev Haralin, Tzekova Maria, Gronkova Naydenka, Dimov Bojidar, Nikolaeva Antonoaneta, Devedzhiev Tsvetan, Mincheva Valentina, D'Ignazio Giuseppe, Dzongowski Peter, Elliott Thomas, Hart Randy, Hoag Gordon, Martinho Valdemar, O'Mahony Michael, Tellier Guy, Pandey Shekhar, Heaton Kenneth, Constance Christian, Phaneuf Denis-Carl, Shu Daniel, Narvaez Nancy Cardenas, Cañon Claudia Olivares Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events New England journal of medicine 2015;372 (16):1489-1499 [PubMed]
• Schwarz Janina C. V., Duivenvoorden Raphaël, Nederveen Aart J., Stroes Erik S. G., VanBavel Ed Endothelial shear stress estimation in the human carotid artery based on Womersley versus Poiseuille flow international journal of cardiovascular imaging 2015;31 (3):585-593 [PubMed]
• Mooij Hans L., Bernelot Moens Sophie J., Gordts Philip L. S. M., Stanford Kristin I., Foley Erin M., van den Boogert Marjolein A. W., Witjes Julia J., Hassing H. Carlijne, Tanck Michael W., van de Sande Michiel A. J., Levels J. Han, Kastelein John J. P., Stroes Erik S. G., Dallinga-Thie Geesje M., Esko Jeff D., Nieuwdorp Max Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans Journal of lipid research 2015;56 (3):665-673 [PubMed]
• Wiegman Albert, Gidding Samuel S., Watts Gerald F., Chapman M. John, Ginsberg Henry N., Cuchel Marina, Ose Leiv, Averna Maurizio, Boileau Catherine, Borén Jan, Bruckert Eric, Catapano Alberico L., Defesche Joep C., Descamps Olivier S., Hegele Robert A., Hovingh G. Kees, Humphries Steve E., Kovanen Petri T., Kuivenhoven Jan Albert, Masana Luis, Nordestgaard Børge G., Pajukanta Päivi, Parhofer Klaus G., Raal Frederick J., Ray Kausik K., Santos Raul D., Stalenhoef Anton F. H., Steinhagen-Thiessen Elisabeth, Stroes Erik S., Taskinen Marja-Riitta, Tybjærg-Hansen Anne, Wiklund Olov Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment European heart journal 2015;36 (36):2425-2437 [PubMed]
• Mooij Hans Leonard Functional consequences of inborn and acquired errors in endothelial glycocalyx heparan sulfates 2015. 212p. ISBN 9789461825476. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Vink H.; Co-supervisors: Nieuwdorp M., Dallinga-Thie G. M.)
• Strang Aart C., van Wijk Diederik F., Mutsaerts Henri J. M. M., Stroes Erik S. G., Nederveen Aart J., Rotmans Joris I., Rabelink Ton J., Box Frieke M. A. Guideline treatment results in regression of atherosclerosis in type 2 diabetes mellitus Diabetes & vascular disease research 2015;12 (2):126-132 [PubMed]
• Stoekenbroek R. M., Rensing K. L., Bernelot Moens S. J., Nieuwdorp M., DeVries J. H., Zwinderman A. H., Stroes E. S., Currie C. J., Hutten B. A. High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events Atherosclerosis 2015;240 (2):318-323 [PubMed]
• Cuchel Marina, Bruckert Eric, Ginsberg Henry N., Raal Frederick J., Santos Raul D., Hegele Robert A., Kuivenhoven Jan Albert, Nordestgaard Børge G., Descamps Olivier S., Steinhagen-Thiessen Elisabeth, Tybjaerg-Hansen Anne, Watts Gerald F., Averna Maurizio, Boileau Catherine, Borén Jan, Catapano Alberico L., Defesche Joep C., Hovingh G. Kees, Humphries Steve E., Kovanen Petri T., Masana Luis, Pajukanta Päivi, Parhofer Klaus G., Ray Kausik K., Stalenhoef Anton F. H., Stroes Erik, Taskinen Marja-Riitta, Wiegman Albert, Wiklund Olov, Chapman M. John, Bore'n Jan Homozigot ailevi hiperkolesterolemi: klinisyenlerin taniyi ve klinik yönetimi geliştirmelerine yönelik yeni anlayişlar ve rehberlik. Avrupa Ateroskleroz Derneği'nin Ailevi Hiperkolesterolemi Üzerine Uzlaşi Paneli yazili görüşü Türk Kardiyoloji Derneği arşivi 2015;43 (Suppl. 1):1-14 [PubMed]
• Strang Aart Christiaan Imaging of arterial wall inflammation 2015. 207p. ISBN 9789461825445. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Tak P. P.; Co-supervisors: Rotmans J. I., Bisoendial R. J.)
• Nahrendorf Matthias, Frantz Stefan, Swirski Filip K., Mulder Willem J. M., Randolph Gwendalyn, Ertl Georg, Ntziachristos Vasilis, Piek Jan J., Stroes Erik S., Schwaiger Markus, Mann Douglas L., Fayad Zahi A. Imaging systemic inflammatory networks in ischemic heart disease Journal of the American College of Cardiology 2015;65 (15):1583-1591 [PubMed]
• Bochem Andrea E., van der Valk Fleur M., Tolani Sonia, Stroes Erik S., Westerterp Marit, Tall Alan R. Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins Arteriosclerosis, thrombosis, and vascular biology 2015;35 (7):1663-1669 [PubMed]
• van Wijk Diederik F., Strang Aart C., Duivenvoorden Raphael, Enklaar Dirk-Jan F., Zwinderman Aeilko H., van der Geest Rob J., Kastelein John J. P., de Groot Eric, Stroes Erik S. G., Nederveen Aart J. Increasing the Spatial Resolution of 3T Carotid MRI Has No Beneficial Effect for Plaque Component Measurement Reproducibility PLoS ONE 2015;10 (7):e0130878 [PubMed]
• Tang Jun, Lobatto Mark E., Hassing Laurien, van der Staay Susanne, van Rijs Sarian M., Calcagno Claudia, Braza Mounia S., Baxter Samantha, Fay Francois, Sanchez-Gaytan Brenda L., Duivenvoorden Raphaël, Sager Hendrik, Astudillo Yaritzy M., Leong Wei, Ramachandran Sarayu, Storm Gert, Pérez-Medina Carlos, Reiner Thomas, Cormode David P., Strijkers Gustav J., Stroes Erik S. G., Swirski Filip K., Nahrendorf Matthias, Fisher Edward A., Fayad Zahi A., Mulder Willem J. M. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation Science advances 2015;1 (3):e1400223 [PubMed]
• van der Valk Fleur M., Sluimer Judith C., Vöö Stefan A., Verberne Hein J., Nederveen Aart J., Windhorst Albert D., Stroes Erik S. G., Lambin Philippe, Daemen Mat J. A. P. In Vivo Imaging of Hypoxia in Atherosclerotic Plaques in Humans JACC. Cardiovascular imaging 2015;8 (11):1340-1341 [PubMed]
• Verweij Simone L., van der Valk Fleur M., Stroes Erik S. G. Novel directions in inflammation as a therapeutic target in atherosclerosis Current opinion in lipidology 2015;26 (6):580-585 [PubMed]
• Lobatto Mark E., Calcagno Claudia, Otten Maarten J., Millon Antoine, Ramachandran Sarayu, Paridaans Maarten P. M., van der Valk Fleur M., Storm Gert, Stroes Erik S. G., Fayad Zahi A., Mulder Willem J. M., Metselaar Josbert M. Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy Nanomedicine: nanotechnology, biology and medicine 2015;11 (5):1133-1140 [PubMed]
• van der Valk Fleur M., van Wijk Diederik F., Lobatto Mark E., Verberne Hein J., Storm Gert, Willems Martine C. M., Legemate Dink A., Nederveen Aart J., Calcagno Claudia, Mani Venkatesh, Ramachandran Sarayu, Paridaans Maarten P. M., Otten Maarten J., Dallinga-Thie Geesje M., Fayad Zahi A., Nieuwdorp Max, Schulte Dominik M., Metselaar Josbert M., Mulder Willem J. M., Stroes Erik S. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration Nanomedicine: nanotechnology, biology and medicine 2015;11 (5):1039-1046 [PubMed]
• Stroes Erik S., Thompson Paul D., Corsini Alberto, Vladutiu Georgirene D., Raal Frederick J., Ray Kausik K., Roden Michael, Stein Evan, Tokgözoğlu Lale, Nordestgaard Børge G., Bruckert Eric, de Backer Guy, Krauss Ronald M., Laufs Ulrich, Santos Raul D., Hegele Robert A., Hovingh G. Kees, Leiter Lawrence A., Mach Francois, März Winfried, Newman Connie B., Wiklund Olov, Jacobson Terry A., Catapano Alberico L., Chapman M. John, Ginsberg Henry N., Leiter Lawrence Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management European heart journal 2015;36 (17):1012-1022 [PubMed]
• Siemelink Marten, den Ruijter Hester, van der Valk Fleur, de Vries Jean-Paul, de Borst Gert Jan, Moll Frans, Stroes Erik, Pasterkamp Gerard Systemic Glucocorticoids Are Associated With Mortality After Carotid Endarterectomy Journal of cardiovascular pharmacology 2015;66 (4):392-398 [PubMed]
• Hovingh G. Kees, Smits Loek P., Stefanutti Claudia, Soran Handrean, Kwok See, de Graaf Jacqueline, Gaudet Daniel, Keyserling Constance H., Klepp Heather, Frick Jennifer, Paolini John F., Dasseux Jean-Louis, Kastelein John J. P., Stroes Erik S. The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study American heart journal 2015;169 (5):736-742.e1 [PubMed]

2014

• Bochem Andrea E., Holleboom Adriaan G., Romijn Johannes A., Hoekstra Menno, Dallinga Geesje M., Motazacker Mahdi M., Hovingh G. Kees, Kuivenhoven Jan A., Stroes Erik S. G. Adrenal Function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT PLoS ONE 2014;9 (5):e90967 [PubMed]
• Rensing Katrijn L., de Jager Saskia C. A., Stroes Erik S., Vos Mariska, Twickler Marcel Th B., Dallinga-Thie Geesje M., de Vries Carlie J. M., Kuiper Johan, Bot Ilze, von der Thüsen Jan H. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice Cardiovascular research 2014;101 (2):277-287 [PubMed]
• Stroes Erik, Colquhoun David, Sullivan David, Civeira Fernando, Rosenson Robert S., Watts Gerald F., Bruckert Eric, Cho Leslie, Dent Ricardo, Knusel Beat, Xue Allen, Scott Rob, Wasserman Scott M., Rocco Michael Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab Journal of the American College of Cardiology 2014;63 (23):2541-2548 [PubMed]
• Duivenvoorden Raphaël, Tang Jun, Cormode David P., Mieszawska Aneta J., Izquierdo-Garcia David, Ozcan Canturk, Otten Maarten J., Zaidi Neeha, Lobatto Mark E., van Rijs Sarian M., Priem Bram, Kuan Emma L., Martel Catherine, Hewing Bernd, Sager Hendrik, Nahrendorf Matthias, Randolph Gwendalyn J., Stroes Erik S. G., Fuster Valentin, Fisher Edward A., Fayad Zahi A., Mulder Willem J. M. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation Nature communications 2014;5:3065 [PubMed]
• Luijendijk P., Bouma B. J., Vriend J. W. J., Groenink M., Vliegen H. W., de Groot E., Pieper P. G., van Dijk A. P. J., Sieswerda G. T., Konings T. C., Stroes E. S., Zwinderman A. H., Mulder B. J. M. Beneficial effect of high dose statins on the vascular wall in patients with repaired aortic coarctation? International journal of cardiology 2014;176 (1):40-47 [PubMed]
• Bernelot Moens Sophie J., Mooij Hans L., Hassing H. Carlijne, Kruit Janine K., Witjes Julia J., van de Sande Michiel A. J., Nederveen Aart J., Xu Ding, Dallinga-Thie Geesje M., Esko Jeffrey D., Stroes Erik S. G., Nieuwdorp Max Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume PLoS ONE 2014;9 (12):e115662 [PubMed]
• Dillingh Marlous R., van Poelgeest Eveline P., Malone Karen E., Kemper Elles M., Stroes Erik S. G., Moerland Matthijs, Burggraaf Jacobus Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers Journal of inflammation (London, England) 2014;11:28
• Schouten Judith, Wit Ferdinand W., Stolte Ineke G., Kootstra Neeltje A., van der Valk Marc, Geerlings Suzanne E., Prins Maria, Reiss Peter, Kooij K. W., van Zoest R. A., Elsenga B. C., Stolte I. G., Martens M., Moll S., Berkel J., Möller L., Visser G. R., Welling C., Zaheri S., Gras L. A. J., van Leeuwen E., Godfried M. H., Goorhuis A., van der Meer J. T. M., Nellen F. J. B., van der Poll T., Prins J. M., Wiersinga W. J., Postema P. G., Bisschop P. H. L. T., Serlie M. J. M., Dekker E., de Rooij S. E. J. A., Vogt L., Portegies P., Schmand B. A., Geurtsen G. J., van Eck-Smit B. L. F., de Jong M., Richel D. J., Verbraak F. D., Demirkaya N., Ruhé H. G., Nieuwkerk P. T., van Steenwijk R. P., Majoie C. B. L. M., Caan M. W. A., van Lunsen H. W., van den Born B. J. H., Stroes E. S. G. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study Clinical infectious diseases 2014;59 (12):1787-1797 [PubMed]
• Cho Leslie, Rocco Michael, Colquhoun David, Sullivan David, Rosenson Robert S., Dent Ricardo, Xue Allen, Scott Rob, Wasserman Scott M., Stroes Erik Design and Rationale of the GAUSS-2 Study Trial: A Double-Blind, Ezetimibe-Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects With Hypercholesterolemia Who Are Intolerant of Statin Therapy Clinical cardiology 2014;37 (3):131-139 [PubMed]
• Noveck Robert, Stroes Erik S. G., Flaim Joann D., Baker Brenda F., Hughes Steve, Graham Mark J., Crooke Rosanne M., Ridker Paul M. Effects of an antisense oligonucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers Journal of the American Heart Association 2014;3 (4):e001084 [PubMed]
• Duivenvoorden Raphaël, Tang Jun, Cormode David P., Mieszawska Aneta J., Izquierdo-Garcia David, Ozcan Canturk, Otten Maarten J., Zaidi Neeha, Lobatto Mark E., van Rijs Sarian M., Priem Bram, Kuan Emma L., Martel Catherine, Hewing Bernd, Sager Hendrik, Nahrendorf Matthias, Randolph Gwendalyn J., Stroes Erik S. G., Fuster Valentin, Fisher Edward A., Fayad Zahi A., Mulder Willem J. M. Erratum: A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation Nature communications 2014;5:3531 [PubMed]
• Colin Sophie, Fanchon Mélanie, Belloy Loic, Bochem Andrea E., Copin Corinne, Derudas Bruno, Stroes Erik S. G., Hovingh G. Kees, Kuivenhoven Jan A., Dallinga-Thie Geesje M., Staels Bart, Chinetti-Gbaguidi Giulia HDL does not influence the polarization of human monocytes toward an alternative phenotype International journal of cardiology 2014;172 (1):179-184 [PubMed]
• Cuchel Marina, Bruckert Eric, Ginsberg Henry N., Raal Frederick J., Santos Raul D., Hegele Robert A., Kuivenhoven Jan Albert, Nordestgaard Børge G., Descamps Olivier S., Steinhagen-Thiessen Elisabeth, Tybjærg-Hansen Anne, Watts Gerald F., Averna Maurizio, Boileau Catherine, Borén Jan, Catapano Alberico L., Defesche Joep C., Hovingh G. Kees, Humphries Steve E., Kovanen Petri T., Masana Luis, Pajukanta Päivi, Parhofer Klaus G., Ray Kausik K., Stalenhoef Anton F. H., Stroes Erik, Taskinen Marja-Riitta, Wiegman Albert, Wiklund Olov, Chapman M. John Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society European heart journal 2014;35 (32):2146-2157 [PubMed]
• Vrieze Anne, Out Carolien, Fuentes Susana, Jonker Lisanne, Reuling Isaie, Kootte Ruud S., van Nood Els, Holleman Frits, Knaapen Max, Romijn Johannes A., Soeters Maarten R., Blaak Ellen E., Dallinga-Thie Geesje M., Reijnders Dorien, Ackermans Mariette T., Serlie Mireille J., Knop Filip K., Holst Jenst J., van der Ley Claude, Kema Ido P., Zoetendal Erwin G., de Vos Willem M., Hoekstra Joost B. L., Stroes Erik S., Groen Albert K., Nieuwdorp Max Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity Journal of hepatology 2014;60 (4):824-831 [PubMed]
• van Wijk Diederik F., Strang Aart C., Duivenvoorden Raphael, Enklaar Dirk-Jan F., van der Geest Rob J., Kastelein John J. P., de Groot Eric, Stroes Erik S. G., Nederveen Aart J. Increasing spatial resolution of 3T MRI scanning improves reproducibility of carotid arterial wall dimension measurements Magma (New York, N.Y.) 2014;27 (3):219-226 [PubMed]
• van Wijk Diederik F. Inflammation in atherosclerosis. Imaging, biomarkers and novel therapeutic opportunities 2014. 298p. ISBN 9789462591790. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: Nederveen A. J., Boekholdt S. M.)
• Bernelot Moens Sophie J., van Capelleveen Julian C., Stroes Erik S. G. Inhibition of ApoCIII: the next PCSK9? Current opinion in lipidology 2014;25 (6):418-422 [PubMed]
• van der Valk Fleur M., Kroon Jeffrey, Potters Wouter V., Thurlings Rogier M., Bennink Roelof J., Verberne Hein J., Nederveen Aart J., Nieuwdorp Max, Mulder Willem J. M., Fayad Zahi A., van Buul Jaap D., Stroes Erik S. G. In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans Journal of the American College of Cardiology 2014;64 (10):1019-1029 [PubMed]
• Kuroda Masayuki, Holleboom Adriaan G., Stroes Erik S. G., Asada Sakiyo, Aoyagi Yasuyuki, Kamata Kouju, Yamashita Shizuya, Ishibashi Shun, Saito Yasushi, Bujo Hideaki Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency Arteriosclerosis, thrombosis, and vascular biology 2014;34 (8):1756-1762 [PubMed]
• Hashemi Nikroo, Odze Robert D., McGowan Mary P., Santos Raul D., Stroes Erik S. G., Cohen David E. Liver histology during Mipomersen therapy for severe hypercholesterolemia Journal of clinical lipidology 2014;8 (6):606-611 [PubMed]
• Mooij H. L., Cabrales P., Bernelot Moens S. J., Xu D., Udayappan S. D., Tsai A. G., van der Sande M. A. J., de Groot E., Intaglietta M., Kastelein J. J. P., Dallinga-Thie G. M., Esko J. D., Stroes E. S., Nieuwdorp M. Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function Journal of the American Heart Association 2014;3 (6):e001274 [PubMed]
• van Wijk Diederik F., Sjouke Barbara, Figueroa Amparo, Emami Hamed, van der Valk Fleur M., MacNabb Megan H., Hemphill Linda C., Schulte Dominik M., Koopman Marion G., Lobatto Mark E., Verberne Hein J., Fayad Zahi A., Kastelein John J. P., Mulder Willem J. M., Hovingh G. Kees, Tawakol Ahmed, Stroes Erik S. G. Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia Journal of the American College of Cardiology 2014;64 (14):1418-1426 [PubMed]
• Kim Yongtae, Lobatto Mark E., Kawahara Tomohiro, Lee Chung Bomy, Mieszawska Aneta J., Sanchez-Gaytan Brenda L., Fay Francois, Senders Max L., Calcagno Claudia, Becraft Jacob, Tun Saung May, Gordon Ronald E., Stroes Erik S. G., Ma Mingming, Farokhzad Omid C., Fayad Zahi A., Mulder Willem J. M., Langer Robert Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis Proceedings of the National Academy of Sciences of the United States of America 2014;111 (3):1078-1083 [PubMed]
• Smits Loek P., Kootte Ruud S., Stroes Erik S. Reversal of atherosclerosis with apolipoprotein A1: back to basics Atherosclerosis 2014;232 (1):217-219 [PubMed]
• Hassing H. Carlijne, Surendran R. Preethi, Derudas Bruno, Verrijken An, Francque Sven M., Mooij Hans L., Bernelot Moens Sophie J., Hart Leen M. 't, Nijpels Giel, Dekker Jacqueline M., Williams Kevin Jon, Stroes Erik S. G., van Gaal Luc F., Staels Bart, Nieuwdorp Max, Dallinga-Thie Geesje M. SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus Obesity (Silver Spring, Md.) 2014;22 (5):1309-1316 [PubMed]
• Strang Aart C., Knetsch Menno L. W., Idu Mirza M., Bisoendial Radjesh J., Kramer Gertjan, Speijer Dave, Koole Leo H., Stroes Erik S. G., Rotmans Joris I. Superior in vivo compatibility of hydrophilic polymer coated prosthetic vascular grafts journal of vascular access 2014;15 (2):95-101 [PubMed]
• Frenkel Wijnanda J. Susceptibility to hyponatremia in the elderly: causes and consequences 2014. 147p. ISBN 9789461086884. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., de Rooij S. E. J. A.; Co-supervisors: van den Born B. J. H., Vogt L.)
• van der Valk Fleur, Hassing Carlijne, Visser Maartje, Thakkar Purav, Mohanan Anookh, Pathak Kaushal, Dutt Chaitanya, Chauthaiwale Vijay, Ackermans Mariette, Nederveen Aart, Serlie Mireille, Nieuwdorp Max, Stroes Erik The effect of a diiodothyronine mimetic on insulin sensitivity in male cardiometabolic patients: a double-blind randomized controlled trial PLoS ONE 2014;9 (2):e86890 [PubMed]
• Vinjé Sarah, Stroes Erik, Nieuwdorp Max, Hazen Stan L. The gut microbiome as novel cardio-metabolic target: the time has come! European heart journal 2014;35 (14):883-887 [PubMed]
• Hegele Robert A., Ginsberg Henry N., Chapman M. John, Nordestgaard Børge G., Kuivenhoven Jan Albert, Averna Maurizio, Borén Jan, Bruckert Eric, Catapano Alberico L., Descamps Olivier S., Hovingh G. Kees, Humphries Steve E., Kovanen Petri T., Masana Luis, Pajukanta Päivi, Parhofer Klaus G., Raal Frederick J., Ray Kausik K., Santos Raul D., Stalenhoef Anton F. H., Stroes Erik, Taskinen Marja-Riitta, Tybjærg-Hansen Anne, Watts Gerald F., Wiklund Olov The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management Lancet. Diabetes and endocrinology 2014;2 (8):655-666 [PubMed]
• Duivenvoorden Raphael, Stroes Erik S. G., Hovingh G. Kees The value of screening for carotid plaque in patients referred for echocardiography Canadian journal of cardiology 2014;30 (10):1148-1149 [PubMed]
• Niesor Eric J., Kallend David, Bentley Darren, Kastelein John J. P., Kees Hovingh G., Stroes Erik S. G. Treatment of low HDL-C subjects with the CETP modulator dalcetrapib increases plasma campesterol only in those without ABCA1 and/or ApoA1 mutations Lipids 2014;49 (12):1245-1249 [PubMed]
• Bochem A. E., van Capelleveen J. C., Dallinga-Thie G. M., Schimmel A. W. M., Motazacker M. M., Tietjen I., Singaraja R. R., Hayden M. R., Kastelein J. J. P., Stroes E. S. G., Hovingh G. K. Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families Clinical genetics 2014;85 (5):433-440 [PubMed]

2013

• Bochem Andrea E., van Wijk Diederik F., Holleboom Adriaan G., Duivenvoorden Raphaël, Motazacker Mahdi M., Dallinga-Thie Geesje M., de Groot Eric, Kastelein John J. P., Nederveen Aart J., Hovingh G. Kees, Stroes Erik S. G. ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden European heart journal 2013;34 (4):286-291 [PubMed]
• Besseling J., Hovingh G. K., Stroes E. S. G. Antisense oligonucleotides in the treatment of lipid disorders: pitfalls and promises Netherlands journal of medicine 2013;71 (3):118-122 [PubMed]
• van Wijk Diederik F., Boekholdt S. Matthijs, Wareham Nicholas J., Ahmadi-Abhari Sara, Kastelein John J. P., Stroes Erik S. G., Khaw Kay-Tee C-Reactive Protein, Fatal and Nonfatal Coronary Artery Disease, Stroke, and Peripheral Artery Disease in the Prospective EPIC-Norfolk Cohort Study Arteriosclerosis, thrombosis, and vascular biology 2013;33 (12):2888-2894 [PubMed]
• Duivenvoorden Raphaël, van Wijk Diederik, Klimas Michael, Kastelein John J. P., Stroes Erik S. G., Nederveen Aart J. Detection of liquid phase cholesteryl ester in carotid atherosclerosis by 1H-MR spectroscopy in humans JACC. Cardiovascular imaging 2013;6 (12):1277-1284 [PubMed]
• Nordestgaard Børge G., Chapman M. John, Humphries Steve E., Ginsberg Henry N., Masana Luis, Descamps Olivier S., Wiklund Olov, Hegele Robert A., Raal Frederick J., Defesche Joep C., Wiegman Albert, Santos Raul D., Watts Gerald F., Parhofer Klaus G., Hovingh G. Kees, Kovanen Petri T., Boileau Catherine, Averna Maurizio, Borén Jan, Bruckert Eric, Catapano Alberico L., Kuivenhoven Jan Albert, Pajukanta Päivi, Ray Kausik, Stalenhoef Anton F. H., Stroes Erik, Taskinen Marja-Riitta, Tybjærg-Hansen Anne Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society European heart journal 2013;34 (45):3478-390a [PubMed]
• Hassing H. Carlyne Glycobiology in cardiometabolic homeostasis 2013. 227p. ISBN 9789461917355. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: Nieuwdorp M., Dallinga-Thie G. M.)
• Bochem Andrea E. HDL cholesterol: atherosclerosis and beyond 2013. 293p. ISBN 9789461823700. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: Hovingh G. K., Kuivenhoven J. A.)
• Smit Kirsten F., Oei Gezina T. M. L., Brevoord Daniel, Stroes Erik S., Nieuwland Rienk, Schlack Wolfgang S., Hollmann Markus W., Weber Nina C., Preckel Benedikt Helium induces preconditioning in human endothelium in vivo Anesthesiology 2013;118 (1):95-104 [PubMed]
• Bochem Andrea E., Holleboom Adriaan G., Romijn Johannes A., Hoekstra Menno, Dallinga-Thie Geesje M., Motazacker Mahdi M., Hovingh G. Kees, Kuivenhoven Jan A., Stroes Erik S. G. High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C Journal of lipid research 2013;54 (6):1698-1704 [PubMed]
• Cormode David P., Fisher Edward A., Stroes Erik S. G., Mulder Willem J. M., Fayad Zahi A. High-density lipoprotein is a nanoparticle, but not all nanoparticles are high-density lipoprotein Proceedings of the National Academy of Sciences of the United States of America 2013;110 (38):E3548 [PubMed]
• Bernelot Moens Sophie J., Hassing Carlijne H., Nieuwdorp Max, Stroes Erik S. G., Dallinga-Thie Geesje M. Hypertriglyceridemia: the future of genetics to guide individualized therapeutic strategies Clinical lipidology 2013;8 (3):321-328
• Duivenvoorden Raphaël Innovative imaging techniques for improved characterization of atherosclerosis and the assessment of novel therapies 2013. 301p. ISBN 9789090277722. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Stroes E. S. G.; Co-supervisors: Nederveen A. J., de Groot E., Mulder W. J. M.)
• Jakulj L., Besseling J., Stroes E. S. G., Groen A. K. Intestinal cholesterol secretion: future clinical implications Netherlands journal of medicine 2013;71 (9):459-465 [PubMed]
• Jakulj L. Intestinal cholesterol transport: measuring cholesterol absorption and its reverse 2013. 176p. ISBN 9789082043709. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Groen A. K., Stroes E. S. G.; Co-supervisor: Vissers M. N.)
• Holleboom Adriaan G., Jakulj Lily, Franssen Remco, Decaris Julie, Vergeer Menno, Koetsveld Joris, Luchoomun Jayraz, Glass Alexander, Hellerstein Marc K., Kastelein John J. P., Hovingh G. Kees, Kuivenhoven Jan Albert, Groen Albert K., Turner Scott M., Stroes Erik S. G. In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1 Journal of lipid research 2013;54 (7):1964-1971 [PubMed]
• Sjouke Barbara, Balak Deepak M. W., Beuers Ulrich, Ratziu Vlad, Stroes Erik S. G. Is mipomersen ready for clinical implementation? A transatlantic dilemma Current opinion in lipidology 2013;24 (4):301-306 [PubMed]
• Eeftinck Schattenkerk Daan W., van den Bogaard Bas, Cammenga Marianne, Westerhof Berend E., Stroes Erik S. G., van den Born Bert-Jan H. Lack of difference between nebivolol/hydrochlorothiazide and metoprolol/hydrochlorothiazide on aortic wave augmentation and central blood pressure Journal of hypertension 2013;31 (12):2447-2454 [PubMed]
• Sondermeijer Brigitte M., Battjes Suzanne, van Dijk Theo H., Ackermans Mariëtte T., Serlie Mireille J., Nieuwdorp Max, Groen Albert K., Dallinga-Thie Geesje M., Stroes Erik S. G. Lactate increases hepatic secretion of VLDL-triglycerides in humans Atherosclerosis 2013;228 (2):443-450 [PubMed]
• Mulders Ties A., Nieuwdorp Max, Stroes Erik S., Vink Hans, Pinto-Sietsma Sara-Joan Non-invasive assessment of microvascular dysfunction in families with premature coronary artery disease International journal of cardiology 2013;168 (5):5026-5028 [PubMed]
• Knaapen M., Kootte R. S., Zoetendal E. G., de Vos W. M., Dallinga-Thie G. M., Levi M. [=Marcel M.], Stroes E. S., Nieuwdorp M. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? Clinical microbiology and infection 2013;19 (4):331-337 [PubMed]
• Jakulj Lily, Mohammed Hussein, van Dijk Theo H., Boer Theo, Turner Scott, Groen Albert K., Vissers Maud N., Stroes Erik S. G. Plasma plant sterols serve as poor markers of cholesterol absorption in man Journal of lipid research 2013;54 (4):1144-1150 [PubMed]
• Mulders Ties A. Premature atherosclerosis: sounds familial 2013. 209p. ISBN 9789461936662. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: Pinto-Sietsma S. J., Vink H.)
• Strang Aart C., Bisoendial Radjesh J., Kootte Ruud S., Schulte Dominik M., Dallinga-Thie Geesje M., Levels Johannes H. M., Kok Marc, Vos Koen, Tas Sander W., Tietge Uwe J. F., Müller Nike, Laudes Matthias, Gerlag Danielle M., Stroes Erik S. G., Tak Paul P. Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis Atherosclerosis 2013;229 (1):174-181 [PubMed]
• Scicluna Brendon P., van 't Veer Cornelis, Nieuwdorp Max, Felsmann Karen, Wlotzka Britta, Stroes Erik S. G., van der Poll Tom Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome PLoS ONE 2013;8 (11):e79051 [PubMed]
• Spijkers Léon J. A. Sphingolipids in essential hypertension and endothelial dysfunction 2013. 224p. ISBN 9789461084019. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., de Mey J. G. R.; Co-supervisors: Peters S. L. M., Alewijnse A. E.)
• Bochem A. E., Kuivenhoven J. A., Stroes E. S. G. The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular disease Current pharmaceutical design 2013;19 (17):3143-3149 [PubMed]

2012

• Visser Maartje E., Witztum Joseph L., Stroes Erik S. G., Kastelein John J. P. Antisense oligonucleotides for the treatment of dyslipidaemia European heart journal 2012;33 (12):1451-1458 [PubMed]
• Visser M. E., Dallinga-Thie G. M., Pinto-Sietsma S. J., Defesche J. C., Stroes E. S., van der Valk P. R. APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required Netherlands journal of medicine 2012;70 (6):278-280 [PubMed]
• Mulders Ties A., van den Bogaard Bas, Bakker Annemieke, Trip Mieke D., Stroes Erik S., van den Born Bert-Jan H., Pinto-Sietsma Sara-Joan Arterial stiffness is increased in families with premature coronary artery disease Heart (British Cardiac Society) 2012;98 (6):490-494 [PubMed]
• Mulders Ties A., Sivapalaratnam Suthesh, Stroes Erik S. G., Kastelein John J. P., Guerci Alan D., Pinto-Sietsma Sara-Joan Asymptomatic Individuals With a Positive Family History for Premature Coronary Artery Disease and Elevated Coronary Calcium Scores Benefit From Statin Treatment A Post Hoc Analysis From the St. Francis Heart Study JACC. Cardiovascular imaging 2012;5 (3):252-260 [PubMed]
• Sondermeijer Brigitte M. Cardiovascular metabolism 2012. 201p. ISBN 9789088914782. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Stroes E. S. G.; Co-supervisor: Serlie M. J. M.)
• van den Bogaard Bas Central hemodynamics and arterial function 2012. 248p. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes Eric S. G.; Co-supervisors: van den Born B. J. H., van Montfrans G. A.)
• Rensing K. L., von der Thüsen J. H., Weijers E. M., Houttuijn Bloemendaal F. M., van Lammeren G. W., Vink A., van der Wal A. C., van Hinsbergh V. W. M., van der Loos C. M., Stroes E. S., Koolwijk P., Twickler Th B. Endothelial insulin receptor expression in human atherosclerotic plaques: Linking micro- and macrovascular disease in diabetes? Atherosclerosis 2012;222 (1):208-215 [PubMed]
• Huijgen R., Stork A. D. M., Defesche J. C., Peter J., Alonso R., Cuevas A., Kastelein J. J. P., Duran M., Stroes E. S. G. Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis Clinical genetics 2012;81 (1):24-28 [PubMed]
• Lobatto Mark E., Calcagno Claudia, Metselaar Josbert M., Storm Gert, Stroes Erik S. G., Fayad Zahi A., Mulder Willem J. M. IMAGING THE EFFICACY OF ANTI-INFLAMMATORY LIPOSOMES IN A RABBIT MODEL OF ATHEROSCLEROSIS BY NON-INVASIVE IMAGING Methods in enzymology 2012;508:211-228 [PubMed]
• Sondermeijer Brigitte M., Klein Twennaar Christian F., Kastelein John J. P., Franssen Eric J. F., Hutten Barbara A., Dallinga-Thie Geesje M., Stroes Erik S. G., Fliers Eric, Twickler Marcel T. B., Serlie Mireille J. Infusion of a Lipid Emulsion in Healthy Men Decreases the Serotonergic Response Neuroendocrinology 2012;95 (4):325-331 [PubMed]
• Hassing H. Carlijne, Mooij Hans, Guo Shuling, Monia Brett P., Chen Keyang, Kulik Wim, Dallinga-Thie Geesje M., Nieuwdorp Max, Stroes Erik S. G., Williams Kevin Jon Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia Hepatology (Baltimore, Md.) 2012;55 (6):1746-1753 [PubMed]
• Rensing Katrijn L. Insulin and insuli-like growth factor-I. Two of a kind in the development of cardiovascular disease? 2012. 204p. ISBN 9789462032095. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisors: Twickler Th B., von der Thüsen J. H.)
• Nieuwkerk Pythia T., Nierman Melchior C., Vissers Maud N., Locadia Mirjam, Greggers-Peusch Phillip, Knape Léon P. M., Kastelein John J. P., Sprangers Mirjam A. G., de Haes Hanneke C., Stroes Erik S. G. Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk American journal of cardiology 2012;110 (5):666-672 [PubMed]
• Franssen Remco, Schimmel Alinda W. M., van Leuven Sander I., Wolfkamp Simone C. S., Stroes Erik S. G., Dallinga-Thie Geesje M. In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL Cholesterol 2012;2012:610741 [PubMed]
• Holleboom Adriaan G., Daniil Georgios, Fu Xiaoming, Zhang Renliang, Hovingh G. Kees, Schimmel Alinda W., Kastelein John J. P., Stroes Erik S. G., Witztum Joseph L., Hutten Barbara A., Tsimikas Sotirios, Hazen Stanley L., Chroni Angeliki, Kuivenhoven Jan Albert Lipid Oxidation in Carriers of Lecithin: Cholesterol Acyltransferase Gene Mutations Arteriosclerosis, thrombosis, and vascular biology 2012;32 (12):3066-+ [PubMed]
• Reuwer Anne Q., Sondermeijer Brigitte M., Battjes Suzanne, van Zijderveld Rogier, Stuijver Danka J. F., Bisschop Peter H., Twickler Marcel Th B., Meijers Joost C. M., Schlingemann Reinier O., Stroes Erik S. Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study Pituitary 2012;15 (4):472-481 [PubMed]
• Visser Maartje E., Wagener Gilbert, Baker Brenda F., Geary Richard S., Donovan Joanne M., Beuers Ulrich H. W., Nederveen Aart J., Verheij Joanne, Trip Mieke D., Basart Dick C. G., Kastelein John J. P., Stroes Erik S. G. Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial European heart journal 2012;33 (9):1142-1149 [PubMed]
• Surendran R. P., Visser M. E., Heemelaar S., Wang J., Peter J., Defesche J. C., Kuivenhoven J. A., Hosseini M., Péterfy M., Kastelein J. J. P., Johansen C. T., Hegele R. A., Stroes E. S. G., Dallinga-Thie G. M. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia Journal of internal medicine 2012;272 (2):185-196 [PubMed]
• van Leuven Sander I., Mendez-Fernandez Yanice V., Wilhelm Ashley J., Wade Nekeithia S., Gabriel Curtis L., Kastelein John J., Stroes Erik S., Tak Paul P., Major Amy S. Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr-/- mice Annals of the rheumatic diseases 2012;71 (3):408-414 [PubMed]
• van der Valk Fleur M., van Wijk Diederik F., Stroes Erik S. G. Novel anti-inflammatory strategies in atherosclerosis Current opinion in lipidology 2012;23 (6):532-539 [PubMed]
• Hassing H. C., Surendran R. P., Mooij H. L., Stroes E. S., Nieuwdorp M., Dallinga-Thie G. M. Pathophysiology of hypertriglyceridemia BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2012;1821 (5):826-832 [PubMed]
• van den Bogaard Bas, Holleboom Adriaan G., Duivenvoorden Raphaël, Hutten Barbara A., Kastelein John J. P., Hovingh G. Kees, Kuivenhoven Jan Albert, Stroes Erik S. G., van den Born Bert-Jan H. Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness Atherosclerosis 2012;225 (2):481-485 [PubMed]
• Stuijver Danka J. F., van Zaane Bregje, Gerdes Victor E. A., Stroes Erik S. Schildklierdiagnostiek bij dyslipidemie Nederlands tijdschrift voor geneeskunde 2012;156 (2):A4301 [PubMed]
• van der Valk Fleurtje M., van Wijk Diederik F., Stroes Erik S. G. Serendipity of post-hoc surrogate marker research European heart journal 2012;33 (23):2897-2898 [PubMed]
• Bisoendial Radjesh J., Tanck Michael W., Golledge Jonathan, Broekhuizen Lysette N., Legemate Dink A., Stroes Erik S. G., Norman Paul E. The association between the gene encoding 5-lipoxygenase activating protein and abdominal aortic aneurysms Atherosclerosis 2012;220 (2):425-428 [PubMed]
• Boekholdt S. Matthijs, Stroes Erik S. G. The interleukin-6 pathway and atherosclerosis Lancet 2012;379 (9822):1176-1178 [PubMed]
• Kootte R. S., Vrieze A., Holleman F., Dallinga-Thie G. M., Zoetendal E. G., de Vos W. M., Groen A. K., Hoekstra J. B. L., Stroes E. S., Nieuwdorp M. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus Diabetes, obesity & metabolism 2012;14 (2):112-120 [PubMed]
• Vrieze Anne, van Nood Els, Holleman Frits, Salojärvi Jarkko, Kootte Ruud S., Bartelsman Joep F. W. M., Dallinga-Thie Geesje M., Ackermans Mariette T., Serlie Mireille J., Oozeer Raish, Derrien Muriel, Druesne Anne, van Hylckama Vlieg Johan E. T., Bloks Vincent W., Groen Albert K., Heilig Hans G. H. J., Zoetendal Erwin G., Stroes Erik S., de Vos Willem M., Hoekstra Joost B. L., Nieuwdorp Max Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome Gastroenterology 2012;143 (4):913-+ [PubMed]

2011

• Postema Pieter G., Regeer Madelien V., van der Valk Paul R., Stroes Erik S. G., Richel Dick J. Blue toe syndrome and sunitinib International journal of clinical oncology / Japan Society of Clinical Oncology 2011;16 (5):574-576 [PubMed]
• Rensing K. L., van Duyvenvoorde H. A., Cramer M. J., Teske A. J., Prokop M., Stroes E. S., Wit J. M., Hermus A. R. M. M., Twickler Th B. Case report: low circulating IGF-I levels due to Acid-Labile Subunit deficiency in adulthood are not associated with early development of atherosclerosis and impaired heart function Growth hormone & IGF research 2011;21 (4):233-237 [PubMed]
• Wang Yanan, Berbée Jimmy F. P., Stroes Erik S., Smit Johannes W. A., Havekes Louis M., Romijn Johannes A., Rensen Patrick C. N. CETP expression reverses the reconstituted HDL-induced increase in VLDL Journal of lipid research 2011;52 (8):1533-1541 [PubMed]
• Visser M. E., Kropman E., Kranendonk M. E., Koppen A., Hamers N., Stroes E. S., Kalkhoven E., Monajemi H. Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C) Diabetologia 2011;54 (7):1639-1644 [PubMed]
• Duivenvoorden Raphaël, Holleboom Adriaan G., van den Bogaard Bas, Nederveen Aart J., de Groot Eric, Hutten Barbara A., Schimmel Alinda W., Hovingh G. Kees, Kastelein John J. P., Kuivenhoven Jan Albert, Stroes Erik S. G. Cholesterol Acyltransferase Gene Mutations Have Accelerated Atherogenesis as Assessed by Carotid 3.0-T Magnetic Resonance Imaging Carriers of Lecithin Journal of the American College of Cardiology 2011;58 (24):2481-2487 [PubMed]
• Bisoendial R. J., Stroes E. S. G., Tak P. P. Critical determinants of cardiovascular risk in rheumatoid arthritis Current pharmaceutical design 2011;17 (1):21-26 [PubMed]
• Stroes Erik S. G., van Wijk Diederik F. Dalcetrapib: turning the tide for CETP inhibition? Lancet 2011;378 (9802):1529-1530 [PubMed]
• Visser Maartje E. Dyslipidemia, sense, antisense or nonsense? 2011. 194p. ISBN 9789461081940. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Stroes E. S. G.; Co-supervisor: Dallinga-Thie G. M.)
• Holleboom Adriaan G. Genetic disorders of HDL metabolism: from model to mechanism 2011. 422p. ISBN 9789461081735. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Stroes E. S. G., Kastelein J. J. P.; Co-supervisors: Kuivenhoven J. A., Hovingh G. K.)
• Broekhuizen Lysette N. Glycocalyx, cardiometabolic disease and inflammation 2011. 183p. ISBN 9789461082008. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Vink H.; Co-supervisors: Stroes E. S. G., Nieuwdorp M.)
• Vergeer A. M. H. HDL genes & HDL drugs 2011. 303p. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisors: Kuivenhoven J. A., Stroes E. S. G.)
• Visser M. E., Lammers N. M., Nederveen A. J., van der Graaf M., Heerschap A., Ackermans M. T., Sauerwein H. P., Stroes E. S., Serlie M. J. Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia Diabetologia 2011;54 (8):2113-2121 [PubMed]
• Holleboom Adriaan G., Karlsson Helen, Lin Ruei-Shiuan, Beres Thomas M., Sierts Jeroen A., Herman Daniel S., Stroes Erik S. G., Aerts Johannes M., Kastelein John J. P., Motazacker Mohammad M., Dallinga-Thie Geesje M., Levels Johannes H. M., Zwinderman Aeilko H., Seidman Jonathan G., Seidman Christine E., Ljunggren Stefan, Lefeber Dirk J., Morava Eva, Wevers Ron A., Fritz Timothy A., Tabak Lawrence A., Lindahl Mats, Hovingh G. Kees, Kuivenhoven Jan Albert Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man Cell metabolism 2011;14 (6):811-818 [PubMed]
• Levels Johannes H. M., Geurts Pierre, Karlsson Helen, Maree Raphael, Ljunggren Stefan, Fornander Louise, Wehenkel Louis, Lindahl Mats, Stroes Erik S. G., Kuivenhoven Jan A., Meijers Joost C. M. High-density lipoprotein proteome dynamics in human endotoxemia Proteome science 2011;9 (1):34 [PubMed]
• Holleboom Adriaan G., Kuivenhoven Jan A., Peelman Frank, Schimmel Alinda W., Peter Jorge, Defesche Joep C., Kastelein John J. P., Hovingh G. Kees, Stroes Erik S., Motazacker Mohammad Mahdi High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations Human mutation 2011;32 (11):1290-1298 [PubMed]
• Spijkers Léon J. A., van den Akker Rob F. P., Janssen Ben J. A., Debets Jacques J., de Mey Jo G. R., Stroes Erik S. G., van den Born Bert-Jan H., Wijesinghe Dayanjan S., Chalfant Charles E., MacAleese Luke, Eijkel Gert B., Heeren Ron M. A., Alewijnse Astrid E., Peters Stephan L. M. Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide PLoS ONE 2011;6 (7):e21817 [PubMed]
• Wiersma Jacobijne J., Verberne Hein J., Meuwese Marijn C., Stroes Erik S. G., van Miert Joram N. I., van Eck-Smit Berthe L. F., Tijssen Jan G. P., Piek Jan J., Trip Mieke D. Myeloperoxidase is not associated with scintigraphic myocardial perfusion abnormalities in type 2 diabetic patients with mild stable anginal complaints Clinica chimica acta; international journal of clinical chemistry 2011;412 (1-2):86-90 [PubMed]
• Franssen Remco, Monajemi Houshang, Stroes Erik S. G., Kastelein John J. P. Obesity and dyslipidemia Medical clinics of North America 2011;95 (5):893-902 [PubMed]
• Leiter L. A., Lundman P., da Silva P. M., Drexel H., Jünger C., Gitt A. K., Absenger Guun, Albrich Ernst, Allinger Berndt, Allinger Stephan, Anacher Gerald, Angermayr Gertraud, Angermeier Hermann, Anzengruber Aneas, Archimanitis Gabriele, Arnsteiner Patricia, Auberger Wolfgang, Azhary Mawaheb, Barfuss Michael, Bauer Christian, Bauer Birgit Elisabeth, Beclin Thomas, Binder Thomas, Binder Gabriele, Böhler Dietmar, Brändle Johann, Breslmair Jörg, Brettlecker Marlis, Bürger Michael, Calvi Inge, Dorfinger Werner, Doringer-Schnepf Elisabeth, Eer Anton, Eckmayr Christine, Eder Franz, Egermann Margit, Erath Michael, Etzinger Michael, Etzinger Claudia, Fiedler Lothar, Filip Wolfgang, Filip Michaela, Föchterle Johann, Fodor Anita, Frieden Thomas, Gareiss Mertens, Gföllner Peter, Bax M., Stroes E. S. G., Twickler Th B. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study Diabetic medicine 2011;28 (11):1343-1351 [PubMed]
• Broekhuizen Lysette N., Boekholdt S. Matthijs, Arsenault Benoit J., Despres Jean-Pierre, Stroes Erik S. G., Kastelein John J. P., Khaw Kay-Tee, Wareham Nicholas J. Physical activity, metabolic syndrome, and coronary risk: the EPIC-Norfolk prospective population study European journal of cardiovascular prevention and rehabilitation 2011;18 (2):209-217 [PubMed]
• Holleboom A. G., Kuivenhoven J. A., van Olden C. C., Peter J., Schimmel A. W., Levels J. H., Valentijn R. M., Vos P., Defesche J. C., Kastelein J. J. P., Hovingh G. K., Stroes E. S. G., Hollak C. E. M. Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase Atherosclerosis 2011;216 (1):161-165 [PubMed]
• den Ruijter Hester M., Franssen Remco, Verkerk Arie O., van Wijk Diederik F., Vaessen Stefan F., Holleboom Adriaan G., Levels Johannes H., Opthof Tobias, Sungnoon Rattapong, Stroes Erik S., Kuivenhoven Jan Albert, Coronel Ruben Reconstituted High-Density Lipoprotein Shortens Cardiac Repolarization Journal of the American College of Cardiology 2011;58 (1):40-44 [PubMed]
• Broekhuizen Lysette N., van Wijk Diederik F., Vink Hans, Stalmach A., Crozier A., Hutten B. A., Kastelein John J. P., Hugenholtz Paul G., Koenig Wolfgang, Stroes Erik S. G. Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors British journal of nutrition 2011;106 (9):1416-1422 [PubMed]
• van Leuven Sander I., Mendez-Fernandez Yanice V., Stroes Erik S., Tak Paul P., Major Amy S. Statin therapy in lupus-mediated atherogenesis: two birds with one stone? Annals of the rheumatic diseases 2011;70 (2):245-248 [PubMed]

2010

• Franssen Remco Abormalities in lipoprotein metabolism: from dysfunctionla HHDL to abnormal processing of triglyceride-rich lipoproteins 2010. 272p. ISBN 9789461080929. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisors: Stroes E. S. G., Dallinga-Thie G. M.)
• Visser Maartje E., Kastelein John Jp, Stroes Erik Sg Apolipoprotein B synthesis inhibition: results from clinical trials Current opinion in lipidology 2010;21 (4):319-323 [PubMed]
• Vergeer Menno, Brunham Liam R., Koetsveld Joris, Kruit Janine K., Verchere C. Bruce, Kastelein John J. P., Hayden Michael R., Stroes Erik S. G. Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction Diabetes care 2010;33 (4):869-874 [PubMed]
• Lampe Fiona C., Duprez Daniel A., Kuller Lewis H., Tracy Russell, Otvos James, Stroes Erik, Cooper David A., Hoy Jennifer, Paton Nick I., Friis-Møller Nina, Neuhaus Jacquie, Liappis Angelike P., Phillips Andrew N. Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2010;54 (3):275-284 [PubMed]
• van Wijk Diederik F., van Leuven Sander I., Sandhu Manjinder S., Tanck Michael W., Hutten Barbara A., Wareham Nicholas J., Kastelein John J. P., Stroes Erik S. G., Khaw Kay-Tee, Boekholdt S. Matthijs Chemokine Ligand 2 Genetic Variants, Serum Monocyte Chemoattractant Protein-1 Levels, and the Risk of Coronary Artery Disease Arteriosclerosis, thrombosis, and vascular biology 2010;30 (7):1460-U466 [PubMed]
• Arsenault Benoit J., Lemieux Isabelle, Després Jean-Pierre, Wareham Nicholas J., Stroes Erik S. G., Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs Comparison between Gradient Gel Electrophoresis and Nuclear Magnetic Resonance Spectroscopy in Estimating Coronary Heart Disease Risk Associated with LDL and HDL Particle Size Clinical chemistry 2010;56 (5):789-798 [PubMed]
• Bisoendial Radjesh J., Boekholdt S. Matthijs, Vergeer Menno, Stroes Erik S. G., Kastelein John J. P. C-reactive protein is a mediator of cardiovascular disease European heart journal 2010;31 (17):2087-U1505 [PubMed]
• Kusters D. M., Homsma S. J. M., Hutten B. A., Twickler M. T. B., Avis H. J., van der Post J. A., Stroes E. S. G. Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy Netherlands journal of medicine 2010;68 (1):299-303 [PubMed]
• Visser Maartje E., Akdim Fatima, Tribble Diane L., Nederveen Aart J., Kwoh T. Jesse, Kastelein John J. P., Trip Mieke D., Stroes Erik S. G. Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia Journal of lipid research 2010;51 (5):1057-1062 [PubMed]
• Akdim Fatima, Visser Maartje E., Tribble Diane L., Baker Brenda F., Stroes Erik S. G., Yu Rosie, Flaim Joann D., Su John, Stein Evan A., Kastelein John J. P. Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia American journal of cardiology 2010;105 (10):1413-1419 [PubMed]
• Broekhuizen L. N., Lemkes B. A., Mooij H. L., Meuwese M. C., Verberne H., Holleman F., Schlingemann R. O., Nieuwdorp M., Stroes E. S. G., Vink H. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus Diabetologia 2010;53 (12):2646-2655 [PubMed]
• Akdim Fatima, Stroes Erik S. G., Sijbrands Eric J. G., Tribble Diane L., Trip Mieke D., Jukema J. Wouter, Flaim Joann D., Su John, Yu Rosie, Baker Brenda F., Wedel Mark K., Kastelein John J. P. Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy Journal of the American College of Cardiology 2010;55 (15):1611-1618 [PubMed]
• Duivenvoorden Raphaël, VanBavel Ed, de Groot Eric, Stroes Erik S. G., Disselhorst Jonathan A., Hutten Barbara A., Laméris Johan S., Kastelein John J. P., Nederveen Aart J. Endothelial shear stress: a critical determinant of arterial remodeling and arterial stiffness in humans--a carotid 3.0-T MRI study Circulation. Cardiovascular imaging 2010;3 (5):578-585 [PubMed]
• Meuwese Marijn C., Broekhuizen Lysette N., Kuikhoven Mayella, Heeneman Sylvia, Lutgens Esther, Gijbels Marion J. J., Nieuwdorp Max, Peutz Carine J., Stroes Erik S. G., Vink Hans, van den Berg Bernard M. Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein e-deficient mice PLoS ONE 2010;5 (12):e14262 [PubMed]
• Zhang Hong, Löwenberg Ester C., Crosby Jeffrey R., Macleod A. Robert, Zhao Chenguang, Gao Dacao, Black Chris, Revenko Alexey S., Meijers Joost C. M., Stroes Erik S., Levi Marcel, Monia Brett P. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk Blood 2010;116 (22):4684-4692 [PubMed]
• Akdim Fatima LDL cholesterol lowering beyond statins 2010. 166p. ISBN 9789085599555. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisor: Stroes E. S. G.)
• Arsenault Benoit J., Després Jean-Pierre, Stroes Erik S. G., Wareham Nicholas J., Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs Lipid assessment, metabolic syndrome and coronary heart disease risk European journal of clinical investigation 2010;40 (12):1081-1093 [PubMed]
• Rana Jamal S., Visser Maartje E., Arsenault Benoit J., Després Jean-Pierre, Stroes Erik S. G., Kastelein John J. P., Wareham Nicholas J., Boekholdt S. Matthijs, Khaw Kay-Tee Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study International journal of cardiology 2010;143 (3):399-404 [PubMed]
• van Leuven Sander I., van Wijk Diederik F., Volger Oscar L., de Vries Jean-Paul P. M., van der Loos Chris M., de Kleijn Dominique V. P., Horrevoets Anton J. G., Tak Paul P., van der Wal Allard C., de Boer Onno J., Pasterkamp Gerard, Hayden Michael R., Kastelein John J. P., Stroes Erik S. Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis Atherosclerosis 2010;211 (1):231-236 [PubMed]
• van Wijk Diederik F., Stroes Erik S. G., Dallinga-Thie G. M. Novel insights into anti-inflammatory actions of HDL Atherosclerosis 2010;212 (2):388-389 [PubMed]
• Strang A. C., Kaasjager H. A. H., Basart D. C. G., Stroes E. S. G. Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands. Part of the dyslipidaemia international survey Netherlands journal of medicine 2010;68 (4):168-174 [PubMed]
• Bisoendial Radjesh J., Stroes Erik S. G., Kastelein John J. P., Tak Paul Peter Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins Nature reviews. Rheumatology 2010;6 (3):157-164 [PubMed]
• Bisoendial Radjesh J., Levi Marcel, Tak Paul-Peter, Stroes Eric S. G. The Prothrombotic State in Rheumatoid Arthritis: An Additive Risk Factor for Adverse Cardiovascular Events Seminars in thrombosis and hemostasis 2010;36 (4):452-457 [PubMed]

2009

• Mingozzi Federico, Meulenberg Janneke J., Hui Daniel J., Basner-Tschakarjan Etiena, Hasbrouck Nicole C., Edmonson Shyrie A., Hutnick Natalie A., Betts Michael R., Kastelein John J., Stroes Erik S., High Katherine A. AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells Blood 2009;114 (10):2077-2086 [PubMed]
• van Leuven S. I., Birjmohun R. S., Franssen R., Bisoendial R. J., de Kort H., Levels J. H. M., Basser R. L., Meijers J. C. M., Kuivenhoven J. A., Kastelein J. J., Stroes E. S. ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans Journal of thrombosis and haemostasis 2009;7 (2):347-354 [PubMed]
• Arsenault Benoit J., Rana Jamal S., Stroes Erik S. G., Després Jean-Pierre, Shah Prediman K., Kastelein John J. P., Wareham Nicholas J., Boekholdt S. Matthijs, Khaw Kay-Tee Beyond Low-Density Lipoprotein Cholesterol Respective Contributions of Non-High-Density Lipoprotein Cholesterol Levels, Triglycerides, and the Total Cholesterol/High-Density Lipoprotein Cholesterol Ratio to Coronary Heart Disease Risk in Apparently Healthy Men and Women Journal of the American College of Cardiology 2009;55 (1):35-41 [PubMed]
• Vergouwen Mervyn D. I., Meijers Joost C. M., Geskus Ronald B., Coert Bert A., Horn Janneke, Stroes Erik S. G., van der Poll Tom, Vermeulen Marinus, Roos Yvo B. W. E. M. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial Journal of cerebral blood flow and metabolism 2009;29 (8):1444-1453 [PubMed]
• Birjmohun Rakesh S., Vergeer Menno, Stroes Erik S. G., Sandhu Manjinder S., Ricketts Sally L., Tanck Michael W., Wareham Nicholas J., Jukema J. Wouter, Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study PLoS ONE 2009;4 (8):e6809 [PubMed]
• van Wijk Diederik F., Stroes Erik S. G., Monaijemi Houshang Changing paradigm in HDL metabolism and cellular effects Clinical lipidology 2009;4 (1):17-27
• Franssen R., Vergeer M., Stroes E. S. G., Kastelein J. J. P. Combination statin-fibrate therapy: safety aspects Diabetes, obesity & metabolism 2009;11 (2):89-94 [PubMed]
• Duivenvoorden Raphaël, de Groot Eric, Afzali Hamid, Vanbavel Ed T., de Boer Onno J., Laméris Johan S., Fayad Zahi A., Stroes Erik S. G., Kastelein John J. P., Nederveen Aart J. Comparison of In Vivo Carotid 3.0-T Magnetic Resonance to B-Mode Ultrasound Imaging and Histology in a Porcine Model JACC. Cardiovascular imaging 2009;2 (6):744-750 [PubMed]
• Bisoendial Radjesh J., Birjmohun Rakesh S., Akdim Fatima, van 't Veer Cornelis, Spek C. Arnold, Hartman Daniel, de Groot Els R., Bankaitis-Davis Danute M., Kastelein John J. P., Stroes Erik S. G. C-Reactive Protein Elicits White Blood Cell Activation in Humans American journal of medicine 2009;122 (6):582.e1-582.e9 [PubMed]
• Stroes E. S. G., Kastelein J. J. P., Bénardeau A., Kuhlmann O., Blum D., Campos L. A., Clerc R. G., Niesor E. J. Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats British journal of pharmacology 2009;158 (7):1763-1770 [PubMed]
• Broekhuizen Lysette N., Mooij Hans L., Kastelein John J. P., Stroes Eric S. G., Vink Hans, Nieuwdorp Max Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease Current opinion in lipidology 2009;20 (1):57-62 [PubMed]
• Arsenault Benoit J., Lemieux Isabelle, Després Jean-Pierre, Gagnon Pascale, Wareham Nicholas J., Stroes Erik S. G., Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study Atherosclerosis 2009;206 (1):276-281 [PubMed]
• El Harchaoui Karim, Arsenault Benoit J., Franssen Remco, Després Jean-Pierre, Hovingh G. Kees, Stroes Erik S. G., Otvos James D., Wareham Nicholas J., Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs High-Density Lipoprotein Particle Size and Concentration and Coronary Risk Annals of internal medicine 2009;150 (2):84-U43 [PubMed]
• van der Steeg Willem A. Improving cardiovascular disease prevention: from risk assessment to novel therapy 2009. 166p. ISBN 9789071382840. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. . J. . P.; Co-supervisors: Kuivenhoven J. A., Stroes E. S. G.)
• Sankatsing Raaj R., Wit Ferdinand W., Vogel Martin, de Groot Eric, Brinkman Kees, Rockstroh Juergen K., Kastelein John J. P., Stroes Erik S. G., Reiss Peter Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors Atherosclerosis 2009;202 (2):589-595 [PubMed]
• van Leuven Sander I. Inflammation and its echo in atherosclerosis 2009. 339p. ISBN 9789490122386. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisor: Stroes E. S. G.)
• Duivenvoorden R., de Groot E., Elsen B. M., Laméris J. S., van der Geest R. J., Stroes E. S., Kastelein J. J. P., Nederveen A. J. In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging Circulation. Cardiovascular imaging 2009;2 (3):235-242 [PubMed]
• Arsenault Benoit J., Stroes Eric S. G., Boekholdt Matthijs S. Is myeloperoxidase a useful marker to predict the risk of future cardiovascular events? Current cardiovascular risk reports 2009;3:137-143
• van Wijk Diederik F., Stroes Erik S. G., Kastelein John J. P. Lipid measures and cardiovascular disease prediction Disease markers 2009;26 (5-6):209-216 [PubMed]
• Hoefer Imo E., Stroes Erik S. G., Pasterkamp Gerard, Levi Marcel M., Reekers Jim A., Verhagen Hence J. M., Meijers Joost C., Humphries John E., Rotmans Joris I. Locally Applied Recombinant Plasmin Results in Effective Thrombolysis in a Porcine Model of Arteriovenous Graft Thrombosis Journal of vascular and interventional radiology 2009;20 (7):951-958 [PubMed]
• Franssen Remco, Sankatsing Raaj R., Hassink Elly, Hutten Barbara, Ackermans Mariette T., Brinkman Kees, Oesterholt René, Arenas-Pinto Alejandro, Storfer Stephen P., Kastelein John J., Sauerwein Hans P., Reiss Peter, Stroes Erik S. Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production Arteriosclerosis, thrombosis, and vascular biology 2009;29 (9):1336-1341 [PubMed]
• Meuwese Marijn C., Mooij Hans L., Nieuwdorp Max, van Lith Bart, Marck Roos, Vink Hans, Kastelein John J. P., Stroes Erik S. G. Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia Journal of lipid research 2009;50 (1):148-153 [PubMed]
• Harchaoui Karim El, Franssen Remco, Hovingh G. Kees, Bisoendial Radjesh J., Stellaard Frans, Kuipers Folkert, Kastelein John J. P., Kuivenhoven Jan Albert, Stroes Erik S. G., Groen Albert K. Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia Atherosclerosis 2009;207 (2):614-616 [PubMed]
• van Werven Jochem R., Hoogduin Johannes M., Nederveen Aart J., van Vliet Andre A., Wajs Ewa, Vandenberk Petra, Stroes Erik S. G., Stoker Jaap Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content Journal of magnetic resonance imaging 2009;30 (2):444-448 [PubMed]
• Stein Evan A., Stroes Erik S. G., Steiner George, Buckley Brendan M., Capponi Alessandro M., Burgess Tracy, Niesor Eric J., Kallend David, Kastelein John J. P. Safety and tolerability of dalcetrapib American journal of cardiology 2009;104 (1):82-91 [PubMed]
• Duivenvoorden Raphaël, de Groot Eric, Stroes Erik S. G., Kastelein John J. P. Surrogate markers in clinical trials-Challenges and opportunities Atherosclerosis 2009;206 (1):8-16 [PubMed]
• Wijbrandts C. A., van Leuven S. I., Boom H. D., Gerlag D. M., Stroes E. G. S., Kastelein J. J. P., Tak P. P. Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis Annals of the rheumatic diseases 2009;68 (8):1316-1321 [PubMed]
• Strang Aart C., Hovingh G. Kees, Stroes Erik S. G., Kastelein John J. P. The genetics of high-density lipoprotein metabolism: clinical relevance for therapeutic approaches American journal of cardiology 2009;104 (10 Suppl):22E-31E [PubMed]
• Vergeer Menno, Stroes Erik S. G. The pharmacology and off-target effects of some cholesterol ester transfer protein inhibitors American journal of cardiology 2009;104 (10 Suppl):32E-38E [PubMed]
• El-Harchaoui Karim The puzzle of high-density lipoprotein in cardiovascular prevention 2009. 173p. ISBN 9789085596042. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisors: Stroes E. S. G., Kuivenhoven J. A.)
• Harchaoui K. E. L., Visser M. E., Kastelein J. J. P., Stroes E. S., Dallinga-Thie G. M. Triglycerides and cardiovascular risk Current cardiology reviews 2009;5 (3):216-222 [PubMed]
• Nieuwdorp M., Meuwese M. C., Mooij H. L., van Lieshout M. H. P., Hayden A., Levi M. [=Marcel M.], Meijers J. C. M., Ince C., Kastelein J. J. P., Vink H., Stroes E. S. G. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation Atherosclerosis 2009;202 (1):296-303 [PubMed]
• Bisoendial R. J., Stroes E. S. G., Tak P. P. Where the immune response meets the vessel wall Netherlands journal of medicine 2009;67 (8):328-333 [PubMed]

2008

• van der Graaf Anouk, Rodenburg Jessica, Vissers Maud N., Hutten Barbara A., Wiegman Albert, Trip Mieke D., Stroes Erik S. G., Wijburg Frits A., Otvos James D., Kastelein John J. P. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia Journal of pediatrics 2008;152 (6):873-878 [PubMed]
• Sankatsing Raaj R. Atherosclerosis in the HIV and Non-HIV setting: detecting and modifying cardiovascular risk 2008. 191p. ISBN 9789071382673. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Reiss P.; Co-supervisor: Stroes E. S. G.)
• van Wissen S., Bastiaansen B. A. J., Stroobants A. K., van den Dool E. J., Idu M. M., Levi M. [=Marcel M.], Stroes E. S. G. Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour--a case report Lupus 2008;17 (6):586-590 [PubMed]
• Vergeer Menno, El-Harchaoui Karim, Stroes Erik S. G. Cholesterol gene polymorphisms and cardiovascular events New England journal of medicine 2008;359 (1):92 [PubMed]
• Vergeer Menno, Bots Michiel L., van Leuven Sander I., Basart Dick C., Sijbrands Eric J., Evans Gregory W., Grobbee Diederick E., Visseren Frank L., Stalenhoef Anton F., Stroes Erik S., Kastelein John J. P. Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials Circulation 2008;118 (24):2515-2522 [PubMed]
• El Harchaoui Karim, Akdim Fatima, Stroes Erik S. G., Trip Mieke D., Kastelein John J. P. Current and future pharmacologic options for the management of patients unable to achieve low-density lipoprotein-cholesterol goals with statins American journal of cardiovascular drugs 2008;8 (4):233-242 [PubMed]
• Burger David, Stroes Erik, Reiss Peter Drug interactions between statins and antiretroviral agents Current opinion in HIV and AIDS 2008;3 (3):247-251 [PubMed]
• Birjmohun Rakesh S., Hovingh G. Kees, Stroes Erik S. G., Hofstra Jorit J., Dallinga-Thie Geesje M., Meijers Joost C. M., Kastelein John J. P., Levi Marcel Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema Clinical therapeutics 2008;30 (12):2314-2323 [PubMed]
• Monajemi Houshang Genes effecting trigliceride metabolism. From steatosis to lipodystrophy 2008. 136p. ISBN 9789090234472. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Horrevoets A. J. G., Pannekoek H.; Co-supervisor: Stroes E. S. G.)
• Birjmohun R. S. HDL on the crossroads of inflammation, coagulation and atherosclerosis 2008. 284p. ISBN 9789090902307. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisor: Stroes E. S. G.)
• van Leuven Sander I., Stroes Erik S., Kastelein John J. P. High-density lipoprotein: A fall from grace? Annals of medicine 2008;40 (8):584-593 [PubMed]
• van der Steeg Wim A., Holme Ingar, Boekholdt S. Matthijs, Larsen Mogens Lytken, Lindahl Christina, Stroes Erik S. G., Tikkanen Matti J., Wareham Nicholas J., Faergeman Ole, Olsson Anders G., Pedersen Terje R., Khaw Kay-Tee, Kastelein John J. P. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies Journal of the American College of Cardiology 2008;51 (6):634-642 [PubMed]
• van der Zee P. M., Meuwese M. C., Verberne H. J., de Ruijter M., van Straalen J. P., Fischer J. C., Sturk A., van Eck-Smit B. L. F., Stroes E. S. G., de Winter R. J. Increases in myeloperoxidase levels after exercise in myocardial perfusion scintigraphy are not induced by myocardial ischemia Clinica chimica acta; international journal of clinical chemistry 2008;395 (1-2):146-150 [PubMed]
• Stroes Erik S., Nierman Melchior C., Meulenberg Janneke J., Franssen Remco, Twisk Jaap, Henny C. Pieter, Maas Mario M., Zwinderman Aeilko H., Ross Colin, Aronica Eleonora, High Katherine A., Levi Marcel M., Hayden Michael R., Kastelein John J., Kuivenhoven Jan Albert Intramuscular Administration of AAV1-Lipoprotein Lipase(S447X) Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients Arteriosclerosis, thrombosis, and vascular biology 2008;28 (12):2303-U264 [PubMed]
• Visser Maartje E., Jakulj Lily, Kastelein John J. P., Stroes Erik S. G. LDL-C-lowering therapy: current and future therapeutic targets Current cardiology reports 2008;10 (6):512-520 [PubMed]
• Nieuwdorp Max, Meuwese Marijn C., Mooij Hans L., Ince Can, Broekhuizen Lysette N., Kastelein John J. P., Stroes Erik S. G., Vink Hans Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability Journal of applied physiology (Bethesda, Md. 2008;104 (3):845-852 [PubMed]
• Levi Marcel, Nieuwdorp Max, Poll Tom van der, Stroes Erik Metabolic modulation of inflammation-induced activation of coagulation Seminars in thrombosis and hemostasis 2008;34 (1):26-32 [PubMed]
• Vergouwen Mervyn D. I., Vermeulen Marinus, Coert Bert A., Stroes Erik S. G., Roos Yvo B. W. E. M. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia Journal of cerebral blood flow and metabolism 2008;28 (11):1761-1770 [PubMed]
• Meuwese Marijn C., Trip Mieke D., van Wissen Sanne, van Miert Jorarn N. I., Kastelein John J. P., Stroes Erik S. G. Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia Atherosclerosis 2008;197 (2):916-921 [PubMed]
• Franssen Remco, Monajemi Houshang, Stroes Erik S. G., Kastelein John J. P. Obesity and Dyslipidemia Endocrinology and metabolism clinics of North America 2008;37 (3):623-+ [PubMed]
• Nieuwdorp M., Vergeer M., Bisoendial R. J., Op 't Roodt J., Levels H., Birjmohun R. S., Kuivenhoven J. A., Basser R., Rabelink T. J., Kastelein J. J. P., Stroes E. S. G. Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus Diabetologia 2008;51 (6):1081-1084 [PubMed]
• Franssen Remco, Visser Maartje E., Kuivenhoven Jan Albert, Kastelein John J. P., Dallinga-Thie Geesje M., Stroes Erik S. G. Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target FUTURE LIPIDOLOGY 2008;3 (4):385-397
• Kastelein John J. P., Akdim Fatima, Stroes Erik S. G., Zwinderman Aeilko H., Bots Michiel L., Stalenhoef Anton F. H., Visseren Frank L. J., Sijbrands Eric J. G., Trip Mieke D., Stein Evan A., Gaudet Daniel, Duivenvoorden Raphael, Veltri Enrico P., Marais A. David, de Groot Eric Simvastatin with or without ezetimibe in familial hypercholesterolemia New England journal of medicine 2008;358 (14):1431-1443 [PubMed]
• Kastelein J. J. P., Akdim F., Stroes E. S. G., Zwinderman A. H., Bots M. L., Stalenhoef A. F. H., Visseren F. L. J., Sijbrands E. J. G., Trip M. D., Stein E. A., Gaudet D., Duivenvoorden R., Veltri E. P., Marais A. D., de Groot E. Simvastatin with or without ezetimibe in familial hypercholesterolemia (vol 358, pg 1431, 2008) New England journal of medicine 2008;358 (18):1977
• van Leuven S. I., Franssen R., Kastelein J. J., Levi M. [=Marcel M.], Stroes E. S. G., Tak P. P. Systemic inflammation as a risk factor for atherothrombosis Rheumatology (Oxford, England) 2008;47 (1):3-7 [PubMed]
• Levi Marcel, Stroes Erik Targeting the prevention of plaque rupture as a new strategy for prevention of acute arterial cardiovascular events Cardiovascular research 2008;78 (3):407-408 [PubMed]
• Meuwese Marijn C. Targeting the vessel wall in cardiovascular prevention 2008. 262p. ISBN 9789085594024. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisors: Stroes E. S. G., Vink H.)
• Bredie Sebastian J. H., Stroes E. S. G., Kastelein J. J. P., Jukema J. W. Van lipidenmetabolisme naar behandelingin: E. E. van der Wall, F. Van de Werf, F. Zijlstra, editors. Cardiologie. Houten: Bohn Stafleu Van Loghum; 2008. p. 23-32, ISBN 9789031348299

2007

• Stroes E. S. G. Abdominale obesitas en cardiometabool risicomanagementAlphen aan de Rijn: Van Zuiden Communications; 2007. ISBN 9789085231615
• Akdim Fatima, El Harchaoui Karim, Stroes Erik S. G., Kastelein John J. P. Antisense apolipoprotein B-100 as novel treatment for hypercholesterolemia: focus on ISIS 301012 FUTURE LIPIDOLOGY 2007;2 (4):387-393
• Akdim Fatima, Stroes Erik S. G., Kastelein John J. P. Antisense apolipoprotein B therapy: where do we stand? Current opinion in lipidology 2007;18 (4):397-400 [PubMed]
• Birjmohun Rakesh S., Dallinga-Thie Geesje M., Kuivenhoven Jan Albert, Stroes Erik S. G., Otvos James D., Wareham Nicholas J., Luben Robert, Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs Apolipoprotein A-II is inversely associated with risk of future coronary artery disease Circulation 2007;116 (18):2029-2035 [PubMed]
• Birjmohun Rakesh S., Bisoendial Radjesh J., van Leuven Sander I., Ackermans Marlette, Zwinderman Aelko, Kastelein John J. P., Stroes Erik S. G., Sauerwein Hans P. A single bolus infusion of C-reactive protein increases gluconeogenesis and plasma glucose concentration in humans Metabolism: clinical and experimental 2007;56 (11):1576-1582 [PubMed]
• Bisoendial Radjesh J., Kastelein John J. P., Stroes Erik S. G. C-reactive protein and atherogenesis: from fatty streak to clinical event Atherosclerosis 2007;195 (2):e10-e18 [PubMed]
• Bisoendial Radjesh J., Kastelein John J. P., Peters Stephan L. M., Levels Johannes H. M., Birjmohun Rakesh, Rotmans Joris I., Hartman Daniel, Meijers Joost C. M., Levi Marcel, Stroes Erik S. G. Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects Journal of lipid research 2007;48 (4):952-960 [PubMed]
• Sankatsing Raaj R., Wit Ferdinand W., Pakker Nadine, Vyankandondera Joseph, Mmiro Francis, Okong Pius, Kastelein John J., Lange Joep M., Stroes Erik S., Reiss Peter Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy Journal of infectious diseases 2007;196 (1):15-22 [PubMed]
• VanTeeffelen Jurgen W., Brands Judith, Stroes Erik S., Vink Hans Endothelial glycocalyx: sweet shield of blood vessels Trends in cardiovascular medicine 2007;17 (3):101-105 [PubMed]
• Nierman Melchior C., Rip Jaap, Kuivenhoven Jan Albert, Sakai Naohiko, Kastelein John J. P., de Sain-van der Velden Monique G. M., Stroes Erik S. G., Prinsen Berthil H. C. M. T. Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes Atherosclerosis 2007;194 (2):446-451 [PubMed]
• van Leuven Sander I., Hezemans Rachel, Levels Johannes H., Snoek Susan, Stokkers Pieter C., Hovingh G. Kees, Kastelein John J. P., Stroes Erik S., de Groot Eric, Hommes Daan W. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease Journal of lipid research 2007;48 (12):2640-2646 [PubMed]
• Monajemi Houshang, Zhang Lin, Li Gang, Jeninga Ellen H., Cao Henian, Maas Mario, Brouwer C. B., Kalkhoven Eric, Stroes Erik, Hegele Robert A., Leff Todd Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma Journal of clinical endocrinology and metabolism 2007;92 (5):1606-1612 [PubMed]
• Stroes E. S. G., de Groot E. Flow-gemedieerde arteriële dilatatie en intima-mediadikte van de carotis als surrogate eindpunten voor vaatwandfunctionaliteit, cardiovasculaire ziekte en ziekterisicoin: H. R. Büller, J. J. P. Kastelein, E. S. G. Stroes, editors. Vasculaire Geneeskunde, 3e herziene druk. Alphen aan de Rijn: Van Zuiden Communications; 2007. p. 193-205, ISBN 9789085231516
• Birjmohun Rakesh S., van Leuven Sander I., Levels Johannes H. M., van 't Veer Cornelis, Kuivenhoven Jan Albert, Meijers Joost C. M., Levi Marcel, Kastelein John J. P., van der Poll Tom, Stroes Erik S. G. High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans Arteriosclerosis, thrombosis, and vascular biology 2007;27 (5):1153-1158 [PubMed]
• van 't Veer Cornelis, van den Pangaart Petra S., van Zoelen Marieke A. D., de Kruif Martijn, Birjmohun Rakesh S., Stroes Eric S., de Vos Alex F., van der Poll Tom Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model Journal of immunology (Baltimore, Md. 2007;179 (10):7110-7120 [PubMed]
• Monajemi Houshang, Stroes Erik, Hegele Robert A., Fliers Eric Inherited lipodystrophies and the metabolic syndrome Clinical endocrinology 2007;67 (4):479-484 [PubMed]
• van den Berg B. M., Nieuwdorp M., Stroes E. S. G., Vink H. Luminal Glycocalyx: protective barrier between endothelial cells and flowing blood.in: William C. Aird, editors. Endothelial Biomedicine. Cambridge: Cambridge University Press; 2007., ISBN 9780521853767
• van Leuven Sander I., Stroes Erik S. G. Mannose-binding lectin and agalactosyl IgG and risk of ischemic heart disease in rheumatoid arthritis: comment on the article by Troelsen et al Arthritis and rheumatism 2007;56 (6):2097; author reply 2097-2097; author reply 2098 [PubMed]
• Nieuwdorp M. Metabolic and vascular dysfunction during hyperglycemia induced inflammation. The role of the endothelial glycocalyx on vascular homeostasis in vivo 2007. 158p. ISBN 9789090221038. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Hoekstra Joost B. L., Kastelein John J. P.; Co-supervisors: Stroes Erik S. G., Vink Hans)
• Deinum J., Stroes E. S. G., Jukema J. W., Peters R. J. G. Nieuwsbrief Vasculaire GeneeskundeAlphen aan de Rijn: Van Zuiden Communications; 2007.
• Nieuwdorp M., Stroes E. S. G., Kastelein J. J. P. Normalization of metabolic syndrome using fenofibrate, metformin or their combination Diabetes, obesity & metabolism 2007;9 (6):869-878 [PubMed]
• Nieuwdorp M., Holleman F., de Groot E., Vink H., Gort J., Kontush A., Chapman M. J., Hutten B. A., Brouwer C. B., Hoekstra J. B. L., Kastelein J. J. P., Stroes E. S. G. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis Diabetologia 2007;50 (6):1288-1293 [PubMed]
• van der Lee Manon, Sankatsing Roaj, Schippers Emile, Vogel Martin, Faetkenheuer Erd, van der Ven Andre, Kroon Frank, Rockstroh Juegen, Wyen Christoph, Baeumer Anselm, de Root Eric, Koopmans Peter, Stroes Erik, Reiss Peter, Burger David Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients Antiviral therapy 2007;12 (7):1127-1132 [PubMed]
• Akdim Fatima, van Leuven Sander I., Kastelein John J. P., Stroes Erik S. G. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque? Current pharmaceutical design 2007;13 (10):1003-1012 [PubMed]
• Birjmohun Rakesh S., Stroes Erik S. G., Kastelein John J. P. Raising high-density lipoprotein cholesterol for better prevention of cardiovascular disease FUTURE LIPIDOLOGY 2007;1 (1):47-54
• van Oostrom O., Nieuwdorp M., Westerweel P. E., Hoefer I. E., Basser R., Stroes E. S. G., Verhaar M. C. Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes Arteriosclerosis, thrombosis, and vascular biology 2007;27 (8):1864-1865 [PubMed]
• van den Bogaard B., van den Born B. J. H., Stroes E. S. G. Renineremmers: een nieuwe klasse bloeddrukverlagende medicatiein: J. Deinum, E. S. G. Stroes, J. W. Jukema, R. J. G. Peters, editors. Nieuwsbrief Vasculaire Geneeskunde. Alphen aan de Rijn: Van Zuiden Communications; 2007. p. 17-19
• van der Steeg Wim A., Boekholdt S. Matthijs, Stein Evan A., El-Harchaoui Karim, Stroes Erik S. G., Sandhu Manjinder S., Wareham Nicholas J., Jukema J. Wouter, Luben Robert, Zwinderman Aeilko H., Kastelein John J. P., Khaw Kay-Tee Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk Annals of internal medicine 2007;146 (9):640-648 [PubMed]
• Birjmohun R. S., Kastelein J. J. P., Poldermans D., Stroes E. S. G., Hostalek U., Assmann G. Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients Current medical research and opinion 2007;23 (7):1707-1713 [PubMed]
• Meuwese Marijn C., Stroes Erik S. G., Hazen Stanley L., van Miert Joram N., Kuivenhoven Jan Albert, Schaub Robert G., Wareham Nicholas J., Luben Robert, Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs Serum Myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals - The EPIC-Norfolk prospective population study Journal of the American College of Cardiology 2007;50 (2):159-165 [PubMed]
• El Harchaoui Karim, van der Steeg Wim A., Stroes Erik S. G., Kastelein John J. P. The role of CETP inhibition in dyslipidemia Current atherosclerosis reports 2007;9 (2):125-133 [PubMed]
• El Harchaoui Karim, van der Steeg Wim A., Stroes Erik S. G., Kuivenhoven Jan Albert, Otvos James D., Wareham Nicholas J., Hutten Barbara A., Kastelein John J. P., Khaw Kay-Tee, Boekholdt S. Matthijs Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study Journal of the American College of Cardiology 2007;49 (5):547-553 [PubMed]
• Büller H. R., Kastelein J. J. P., Stroes E. S. G. Vasculaire Geneeskunde, 3e herziene drukAlphen aan de Rijn: Van Zuiden Communications; 2007. ISBN 9789085231516

2006

• Meuwese Marijn C., Franssen Remco, Stroes Erik S. G., Kastelein John J. P. And then there were acyl coenzyme A:cholesterol acyl transferase inhibitors Current opinion in lipidology 2006;17 (4):426-430 [PubMed]
• van Leuven S. I., Kastelein J. J. P., D'Cruz D. P., Hughes G. R., Stroes E. S. Atherogenesis in rheumatology Lupus 2006;15 (3):117-121 [PubMed]
• Klerkx Anke H. E. M., El Harchaoui Karim, van der Steeg Wim A., Boekholdt S. Matthijs, Stroes Erik S. G., Kastelein John J. P., Kuivenhoven Jan Albert Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis Arteriosclerosis, thrombosis, and vascular biology 2006;26 (4):706-715 [PubMed]
• Birjmohun R. S., van der Steeg W. A., Stroes E. S. G., Kastelein J. J. P. De rol van het 'high-density'-lipoproteine (HDL)-partikel in de atherogenese en de mogelijkheden om de concentratie daarvan te verhogen Nederlands tijdschrift voor geneeskunde 2006;150 (41):2245-2250 [PubMed]
• Nieuwdorp Max, Mooij Hans L., Kroon Jojanneke, Atasever Bektas, Spaan Jos A. E., Ince Can, Holleman Frits, Diamant Michaela, Heine Robert J., Hoekstra Joost B. L., Kastelein John J. P., Stroes Erik S. G., Vink Hans Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes Diabetes 2006;55 (4):1127-1132 [PubMed]
• Rotmans Joris I., Heyligers Jan M. M., Stroes Erik S. G., Pasterkamp Gerard Endothelial progenitor cell-seeded grafts: rash and risky Canadian journal of cardiology 2006;22 (13):1113-1116 [PubMed]
• Rotmans Joris I., Heyligers Jan M. M., Stroes Erik S. G., Pasterkamp Gerard Endothelial progenitor cell-seeded grafts: rash and risky Canadian journal of cardiology 2006;22 (11):929-932 [PubMed]
• van den Berg Bernard M., Nieuwdorp Max, Stroes Erik S. G., Vink Hans Glycocalyx and endothelial (dys) function: from mice to men Pharmacological reports 2006;58 (Suppl):75-80 [PubMed]
• Bisoendial R. J. High-density lipoprotein and C-reactive protein, friend and foe in cardiovascular disease 2006. 174p. ISBN 9789090209784. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisor: Stroes E. S. G.)
• Rip Jaap, Nierman Melchior C., Ross Colin J., Jukema Jan Wouter, Hayden Michael R., Kastelein John J. P., Stroes Erik S. G., Kuivenhoven Jan Albert Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation Arteriosclerosis, thrombosis, and vascular biology 2006;26 (6):1236-1245 [PubMed]
• Nierman M. C. Lipoprotein lipase S477X. From beneficial gene variant to gene therapy 2006. 254p. ISBN 9789090213101. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisors: Stroes E. S. G., Kuivenhoven J. A.)
• Nieuwdorp Max, van Haeften Timon W., Gouverneur Mirella C. L. G., Mooij Hans L., van Lieshout Miriam H. P., Levi Marcel, Meijers Joost C. M., Holleman Frits, Hoekstra Joost B. L., Vink Hans, Kastelein John J. P., Stroes Erik S. G. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo Diabetes 2006;55 (2):480-486 [PubMed]
• van Leuven S. I., Kastelein J. J. P., Hayden M. R., Stroes E. S. Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis? Lupus 2006;15 (11 Suppl. S):11-17
• van Leuven Sander I., Kastelein John J. P., Allison Anthony C., Hayden Michael R., Stroes Erik S. G. Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles? Cardiovascular research 2006;69 (2):341-347 [PubMed]
• Keller Tymen T., van Leuven Sander I., Meuwese Marijn C., Wareham Nicholas J., Luben Robert, Stroes Erik S., Hack C. Erik, Levi Marcel, Khaw Kay-Tee, Boekholdt S. Matthijs Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women Arteriosclerosis, thrombosis, and vascular biology 2006;26 (10):2345-2350 [PubMed]
• Gouverneur M., Berg B., Nieuwdorp M., Stroes E., Vink H. Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress Journal of internal medicine 2006;259 (4):393-400 [PubMed]

2005

• Bisoendial Radjesh J., Kastelein John J. P., Levels Johannes H. M., Zwaginga Jaap J., van den Bogaard Bas, Reitsma Pieter H., Meijers Joost C. M., Hartman Daniel, Levi Marcel, Stroes Erik S. G. Activation of inflammation and coagulation after infusion of C-reactive protein in humans Circulation research 2005;96 (7):714-716 [PubMed]
• van Leuven Sander I., Kastelein John J. P., Hayden Michael R., d'Cruz David, Hughes Graham R., Stroes Erik S. Cardiovascular disease in systemic lupus erythematosus: has the time for action come? Current opinion in lipidology 2005;16 (5):501-506 [PubMed]
• Nierman Melchior C., Rip Jaap, Kuivenhoven Jan-Albert, van Raalte Daniel H., Hutten Barbara A., Sakai Naohiko, Kastelein John J. P., Stroes Erik S. G. Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance Metabolism: clinical and experimental 2005;54 (11):1499-1503 [PubMed]
• Bisoendial Radjesh J., Hovingh G. Kees, El Harchaoui Karim, Levels Johannes H. M., Tsimikas Sotirios, Pu Kewei, Zwinderman Aeilko E., Kuivenhoven Jan Albert, Kastelein John J. P., Stroes Erik S. G. Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia Arteriosclerosis, thrombosis, and vascular biology 2005;25 (9):E133-E134 [PubMed]
• Birjmohun Rakesh S., Hutten Barbara A., Kastelein John J. P., Stroes Erik S. G. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds - A meta-analysis of randomized controlled trials Journal of the American College of Cardiology 2005;45 (2):185-197 [PubMed]
• Nierman Melchior C., Prinsen Berthil H. C. M. T., Rip Jaap, Veldman Robert Jan, Kuivenhoven Jan Albert, Kastelein John J. P., de Sain-van der Velden Monique G. M., Stroes Erik S. G. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers Arteriosclerosis, thrombosis, and vascular biology 2005;25 (11):2410-2415 [PubMed]
• Birjmohun R. M., Stroes E. S. G., Kastelein J. J. P. Future strategies in the management of dyslipidemia Future cardiology 2005;1 (2):127-130
• Nierman M. C., Rip J., Twisk J., Meulenberg J. J. M., Kastelein J. J. P., Stroes E. S. G., Kuivenhoven J. A. Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice Netherlands journal of medicine 2005;63 (1):14-19 [PubMed]
• Rip Jaap, Nierman Melchior C., Sierts Jeroen A., Petersen Wilma, van den Oever Karin, van Raalte Daniel, Ross Colin J. D., Hayden Michael R., Bakker Andrew C., Dijkhuizen Paul, Hermens Wim T., Twisk Jaap, Stroes Erik, Kastelein John J. P., Kuivenhoven Jan Albert, Meulenberg Janneke M. Gene therapy for lipoprotein lipase deficiency: Working toward clinical application Human gene therapy 2005;16 (11):1276-1286 [PubMed]
• Stroes E. S. G. Hart- en vaatziekten, dl. 1. Cardiovasculaire preventie in perspectiefLeusden: Mark Two Communications bv; 2005.
• Rotmans Joris I., Pasterkamp Gerard, Verhagen Hence J. M., Pattynama Peter M. T., Blankestijn Peter J., Stroes Erik S. G. Hemodialysis access graft failure: Time to revisit an unmet clinical need? Journal of nephrology 2005;18 (1):9-20 [PubMed]
• Sankatsing Raaj R., Fouchier Sigrid W., de Haan Stefan, Hutten Barbara A., de Groot Eric, Kastelein John J. P., Stroes Erik S. G. Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia Arteriosclerosis, thrombosis, and vascular biology 2005;25 (9):1979-1984 [PubMed]
• Nieuwdorp Max, Stroes Erik S. G., Meijers Joost C. M., Büller Harry Hypercoagulability in the metabolic syndrome Current opinion in pharmacology 2005;5 (2):155-159 [PubMed]
• Bisoendial Radjesh, Kastelein John, Stroes Erik In response to van den Berg et al: on the direct actions of CRP in humans Circulation research 2005;97 (7):e71 [PubMed]
• Rotmans Joris I., Heyligers Jan M. M., Verhagen Hence J. M., Velema Evelyn, Nagtegaal Machiel M., de kleijn Dominique P. V., de Groot Flip G., Stroes Erik S. G., Pasterkamp Gerard In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts Circulation 2005;112 (1):12-18 [PubMed]
• Bisoendial Radjesh, Birjmohun Rakesh, Keller Tymen, van Leuven Sander, Levels Han, Levi Marcel, Kastelein John, Stroes Erik In vivo effects of C-reactive protein (CRP)-infusion into humans Circulation research 2005;97 (12):e115-e116 [PubMed]
• Rotmans Joris I., Stroes Erik S. G., Pasterkamp Gerard Letter regarding article by Luo et al, "Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs" Circulation 2005;112 (12):E153 [PubMed]
• Rotmans J. I., Heyligers J. M. M., Verhagen H. J. M., Velema E., de Kleijn D. P. V., Pasterkamp G., Nagtegaal M. M., Stroes E. S. G., de Groot P. G. Letter regarding article by Rotmans et al, "In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts" - Response Circulation 2005;112 (24):E359-E360
• Rotmans Joris I., Pattynama Peter M. T., Verhagen Hence J. M., Hino Ichiro, Velema Evelyn, Pasterkamp Gerard, Stroes Erik S. G. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts - A 4-week follow-up study Circulation 2005;111 (12):1537-1542 [PubMed]
• Stroes Erik Statins and LDL-cholesterol lowering: an overview Current medical research and opinion 2005;21 (Suppl. 6):S9-S16 [PubMed]
• Sankatsing Raaj R., de Groot Eric, Jukema J. Wouter, de Feyter Pim J., Pennell Dudley J., Schoenhagen Paul, Nissen Steven E., Stroes Erik S. G., Kastelein John J. P. Surrogate markers for atherosclerotic disease Current opinion in lipidology 2005;16 (4):434-441 [PubMed]
• Nieuwdorp Max, Meuwese Marijn C., Vink Hans, Hoekstra Joost B. L., Kastelein John J. P., Stroes Erik S. G. The endothelial glycocalyx: a potential barrier between health and vascular disease Current opinion in lipidology 2005;16 (5):507-511 [PubMed]
• Rotmans J. I. Therapeutic strategies to prevent stenosis in arteriovenous grafts for hemodialysis. Studies in a porcine arteriovenous graft model 2005. 160p. ISBN 9789090186344. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisors: Stroes E. S. G., Pasterkamp G.)

2004

• Hovingh G. Kees, Brownlie Alison, Bisoendial Radjesh J., Dube Marie Pierre, Levels Johannes H. M., Petersen Wilma, Dullaart Robin P. F., Stroes Erik S. G., Zwinderman Aeilko H., de Groot Eric, Hayden Michael R., Kuivenhoven Jan Albert, Kastelein John J. P. A novel ApoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease Journal of the American College of Cardiology 2004;44 (7):1429-1435 [PubMed]
• de Grooth Greetje J., Klerkx Anke H. E. M., Stroes Erik S. G., Stalenhoef Anton F. H., Kastelein John J. P., Kuivenhoven Jan Albert A review of CETP and its relation to atherosclerosis Journal of lipid research 2004;45 (11):1967-1974 [PubMed]
• Stroes E. S. G., de Groot E. Flow-gemedieerde arteriële dilatatie en carotis-intima-mediadikte als surrogate eindpunten voor vaatwandfunctionaliteit, cardiovasculiare ziekte en ziekterisicoin: H. R. Büller, J. J. P. Kastelein, E. S. G. Stroes, editors. Vasculaire geneeskunde; 2e herz dr. Alphen a/d Rijn: Van Zuiden; 2004. p. 189-199
• Birjmohun R. S., Hutten B. A., Kastelein J. J. P., Stroes E. S. G. Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice Netherlands journal of medicine 2004;62 (7):229-234 [PubMed]
• Rotmans Joris I., Verhagen Hence J. M., Velema Evelyn, de kleijn Dominique P. V., van den Heuvel Mieke, Kastelein John J. P., Pasterkamp Gerard, Stroes Erik S. G. Local overexpression of C-type natriuretic peptide ameliorates vascular adaptation of porcine hemodialysis grafts Kidney international 2004;65 (5):1897-1905 [PubMed]
• Rotmans Joris I., Velema Evelyn, Verhagen Hence J. M., Blankensteijn Jan D., de kleijn Dominique P. V., Stroes Erik S. G., Pasterkamp Gerard Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model Journal of vascular surgery 2004;39 (2):432-439 [PubMed]
• van Leth Frank, Phanuphak Prahpan, Stroes Erik, Gazzard Brian, Cahn Pedro, Raffi François, Wood Robin, Bloch Mark, Katlama Christine, Kastelein John J. P., Schechter Mauro, Murphy Robert L., Horban Andrzej, Hall David B., Lange Joep M. A., Reiss Peter Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1 PLoS medicine 2004;1 (1):e19-74 [PubMed]
• Fruchart Jean-Charles, Nierman Melchior C., Stroes Erik S. G., Kastelein John J. P., Duriez Patrick New risk factors for atherosclerosis and patient risk assessment Circulation 2004;109 (23 Suppl 1):III15-III19 [PubMed]
• Kastelein John J. P., Stroes Erik S. G., de Groot Eric Subclinical atherosclerosis as a target of therapy: Potential role of statins American journal of cardiology 2004;93 (6):737-740 [PubMed]
• Büller H. R., Kastelein J. J. P., Stroes E. S. G. Vasculaire geneeskundeAlphen a/d Rijn: Van Zuiden; 2004.
• Büller H. R., Kastelein J. J. P., Stroes E. S. G. Vasculaire geneeskundeAlphen a/d Rijn: Van Zuiden; 2004.

2003

• de Jongh S., Vissers M. N., Rol P., Bakker H. D., Kastelein J. J. P., Stroes E. S. G. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia Journal of inherited metabolic disease 2003;26 (4):343-351 [PubMed]
• Rotmans J. I., Velema E., Verhagen H. J. M., Blankensteijn J. D., Kastelein J. J. P., de Kleijn D. P. V., Yo M., Pasterkamp G., Stroes E. S. G. Rapid, arteriovenous graft failure due to intimal hyperplasia: A porcine, bilateral, carotid arteriovenous graft model Journal of surgical research 2003;113 (1):161-171 [PubMed]
• Bisoendial Radjesh J., Hovingh G. Kees, Levels Johannes H. M., Lerch Peter G., Andresen Irmgard, Hayden Michael R., Kastelein John J. P., Stroes Erik S. G. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein Circulation 2003;107 (23):2944-2948 [PubMed]
• Lilien Marc R., Stroes Erik S., Op't Roodt Jos, de Jongh Saskia, Schröder Cornelis H., Koomans Hein A. Vascular function in children after renal transplantation American journal of kidney diseases 2003;41 (3):684-691 [PubMed]

2002

• Diercks Gilles F. H., Stroes Erik S. G., van Boven Ad J., van Roon Arie M., Hillege Hans L., de Jong Paul E., Smit Andries J., Gans Rijk O. B., Crijns Harry J. G. M., Rabelink Ton J., van Gilst Wiek H. Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects Diabetes care 2002;25 (5):936-937 [PubMed]
• de Jongh Saskia, Lilien Marc R., Op't Roodt Jos, Stroes Erik S. G., Bakker Henk D., Kastelein John J. P. Early statin therapy restores endothelial function in children with familial hypercholesterolemia Journal of the American College of Cardiology 2002;40 (12):2117-2121 [PubMed]
• Monnink Stefan H. J., van Haelst Paul L., van Boven Ad J., Stroes Erik S. G., Tio René A., Plokker Thijs W. M., Smit Andries J., Veeger Nic J. G. M., Crijns Harry J. G. M., van Gilst Wiek H. Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests Journal of investigative medicine 2002;50 (1):19-24 [PubMed]
• de Jongh Saskia, Lilien Marc R., Bakker Henk D., Hutten Barbara A., Kastelein John J. P., Stroes Erik S. G. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia Atherosclerosis 2002;163 (1):193-197 [PubMed]
• Rooyakkers T. M., Stroes E. S. G., Kooistra M. P., van Faassen E. E., Hider R. C., Rabelink T. J., Marx J. J. M. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo European journal of clinical investigation 2002;32 (Suppl. 1):9-16 [PubMed]
• Stroes E. S. G. Flow-gemedieerde vaatverwijding in de arteria brachialisin: H. R. Büller, J. J. P. Kastelein, E. S. G. Stroes, editors. Vasculaire geneeskunde. S.l.: Van Zuiden Communications; 2002. p. 169-208
• van Etten Ronald W., de Koning Eelco J. P., Honing Marina L., Stroes Erik S., Gaillard Carlo A., Rabelink Ton J. Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes Arteriosclerosis, thrombosis, and vascular biology 2002;22 (5):799-804 [PubMed]
• Bisoendial Radjesh J., Hovingh G. Kees, de Groot Eric, Kastelein John J. P., Lansberg Peter J., Stroes Erik S. G. Measurement of subclinical atherosclerosis: beyond risk factor assessment Current opinion in lipidology 2002;13 (6):595-603 [PubMed]
• Hijmering Michel L., Stroes Erik S. G., Olijhoek Jobien, Hutten Barbara A., Blankestijn Peter J., Rabelink Ton J. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation Journal of the American College of Cardiology 2002;39 (4):683-688 [PubMed]
• Diercks Gilles F. H., Stroes Erik S. G., van Boven Ad J., van Roon Arie M., Hillege Hans L., de Jong P. E., Smit Andries J., Gans Rijk O. B., Crijns Harry J. G. M., Rabelink Ton J., van Gilst Wiek H. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects Atherosclerosis 2002;163 (1):121-126 [PubMed]
• Büller H. R., Kastelein J. J. P., Stroes E. S. G. Vasculaire geneeskundeAlphen a/d Rijn: Van Zuiden Communications; 2002. ISBN 9789076906348

2001

• Wilmink H. W., Twickler M. B., Banga J. D., Dallinga-Thie G. M., Eeltink H., Erkelens D. W., Rabelink T. J., Stroes E. S. Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles Cardiovascular research 2001;50 (3):577-582 [PubMed]

1997

• Stroes E., Kastelein J., Cosentino F., Erkelens W., Wever R., Koomans H., Lüscher T., Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia Journal of clinical investigation 1997;99 (1):41-46 [PubMed]